> top > docs > PMC:3218875 > spans > 25238-27334 > annotations

PMC:3218875 / 25238-27334 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T14064 1525-1528 Positive_regulation denotes via
T14063 1492-1501 Binding denotes recruited
T14062 1458-1465 Positive_regulation denotes induced
T14061 1397-1407 Gene_expression denotes expression
T14060 1355-1362 Gene_expression denotes produce
T14059 759-768 Gene_expression denotes expressed
T14058 2006-2010 Protein denotes CYLD
T14057 1897-1901 Protein denotes RANK
T14056 1868-1872 Protein denotes CYLD
T14055 1755-1758 Protein denotes p62
T14054 1658-1663 Protein denotes TRAF6
T14053 1624-1628 Protein denotes CYLD
T14052 1586-1600 Protein denotes sequestosome 1
T14051 1567-1570 Protein denotes p62
T14050 1533-1542 Protein denotes ubiquitin
T14049 1519-1524 Protein denotes TRAF6
T14048 1452-1457 Protein denotes RANKL
T14047 1392-1396 Protein denotes CYLD
T14046 1321-1326 Protein denotes RANKL
T14045 1182-1186 Protein denotes CYLD
T14044 1095-1099 Protein denotes RANK
T14043 1052-1056 Protein denotes CYLD
T14042 905-909 Protein denotes CYLD
T14041 747-750 Protein denotes A20
T14040 710-714 Protein denotes CYLD
T14039 695-698 Protein denotes A20
T14038 646-649 Protein denotes A20
T14037 605-609 Protein denotes TAK1
T14036 596-600 Protein denotes RIP1
T14035 589-594 Protein denotes TRAF7
T14034 582-587 Protein denotes TRAF6
T14033 575-580 Protein denotes TRAF2
T14032 569-573 Protein denotes NEMO
T14031 436-440 Protein denotes RANK
T14030 350-373 Protein denotes deubiquitinating enzyme
T14029 340-344 Protein denotes CYLD
T14028 147-151 Protein denotes CYLD
T14027 41-45 Protein denotes CYLD
T14026 24-39 Protein denotes Cylindromatosis
T14025 0-15 Protein denotes Cylindromatosis
R9294 T14027 T14026 equivalentTo CYLD,Cylindromatosis
R9295 T14041 T14059 themeOf A20,expressed
R9296 T14047 T14061 themeOf CYLD,expression
R9297 T14049 T14063 themeOf TRAF6,recruited
R9298 T14052 T14063 themeOf sequestosome 1,recruited
R9299 T14052 T14064 causeOf sequestosome 1,via
R9300 T14063 T14064 themeOf recruited,via

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T15018 2095-2096 . denotes .
T15017 2093-2095 NNP denotes RA
T15016 2090-2092 IN denotes as
T15015 2085-2089 JJ denotes such
T15014 2075-2084 NNS denotes disorders
T15013 2070-2074 NN denotes bone
T15012 2067-2069 IN denotes of
T15011 2057-2066 NN denotes pathology
T15010 2053-2056 DT denotes the
T15009 2050-2052 IN denotes in
T15008 2041-2049 VBN denotes involved
T15007 2034-2040 NN denotes factor
T15006 2026-2033 JJ denotes genetic
T15005 2016-2025 JJ denotes potential
T15004 2014-2015 DT denotes a
T15003 2011-2013 IN denotes as
T15002 2006-2010 NNP denotes CYLD
T15001 1997-2005 VBP denotes indicate
T15000 1993-1996 CC denotes and
T14999 1974-1992 NN denotes osteoclastogenesis
T14998 1971-1973 IN denotes of
T14997 1960-1970 NN denotes regulation
T14996 1951-1959 JJ denotes negative
T14995 1947-1950 DT denotes the
T14994 1944-1946 IN denotes in
T14993 1939-1943 NN denotes role
T14992 1935-1938 JJ denotes key
T14991 1933-1934 DT denotes a
T14990 1927-1932 NNS denotes plays
T14989 1916-1926 VBG denotes signalling
T14988 1910-1915 NN denotes NF-κB
T14987 1897-1909 JJ denotes RANK-induced
T14986 1894-1896 IN denotes of
T14985 1882-1893 NN denotes inhibi-tion
T14984 1868-1881 JJ denotes CYLD-mediated
T14983 1863-1867 IN denotes that
T14982 1855-1862 VBP denotes suggest
T14981 1846-1854 NNS denotes findings
T14980 1840-1845 DT denotes These
T14979 1838-1839 . denotes .
T14978 1837-1838 NNP denotes ]
T14977 1835-1837 CD denotes 66
T14976 1834-1835 NNP denotes [
T14975 1829-1833 NN denotes loss
T14974 1824-1828 NN denotes bone
T14973 1812-1823 JJ denotes progressive
T14972 1804-1811 VB denotes develop
T14971 1800-1803 CC denotes and
T14970 1781-1799 NN denotes osteoclastogenesis
T14969 1772-1780 JJ denotes abnormal
T14968 1764-1771 NN denotes display
T14967 1759-1763 RB denotes also
T14966 1755-1758 CD denotes p62
T14965 1752-1754 IN denotes of
T14964 1747-1751 NN denotes form
T14963 1739-1746 VBN denotes mutated
T14962 1737-1738 DT denotes a
T14961 1726-1736 VBG denotes expressing
T14960 1721-1725 NNS denotes mice
T14959 1710-1720 JJ denotes transgenic
T14958 1705-1709 IN denotes that
T14957 1694-1704 VBG denotes mentioning
T14956 1688-1693 JJ denotes worth
T14955 1685-1687 VBZ denotes is
T14954 1682-1684 PRP denotes it
T14953 1680-1681 , denotes ,
T14952 1673-1680 NN denotes context
T14951 1668-1672 DT denotes this
T14950 1665-1667 IN denotes In
T14949 1663-1664 . denotes .
T14948 1658-1663 CD denotes TRAF6
T14947 1655-1657 IN denotes of
T14946 1638-1654 NN denotes deubiquitination
T14945 1624-1637 JJ denotes CYLD-mediated
T14944 1620-1623 DT denotes the
T14943 1617-1619 IN denotes by
T14942 1608-1616 VBN denotes followed
T14941 1606-1607 , denotes ,
T14940 1605-1606 NNP denotes ]
T14939 1603-1605 CD denotes 65
T14938 1602-1603 NNP denotes [
T14937 1600-1601 -RRB- denotes )
T14936 1599-1600 CD denotes 1
T14935 1586-1598 JJ denotes sequestosome
T14934 1583-1585 IN denotes as
T14933 1577-1582 VBN denotes known
T14932 1572-1576 RB denotes also
T14931 1571-1572 -LRB- denotes (
T14930 1567-1570 NN denotes p62
T14929 1559-1566 NN denotes protein
T14928 1551-1558 NN denotes adaptor
T14927 1533-1550 JJ denotes ubiquitin-binding
T14926 1529-1532 DT denotes the
T14925 1525-1528 IN denotes via
T14924 1519-1524 CD denotes TRAF6
T14923 1505-1518 VBN denotes ubiquitinated
T14922 1502-1504 TO denotes to
T14921 1492-1501 VBN denotes recruited
T14920 1489-1491 VBZ denotes is
T14919 1485-1488 CC denotes and
T14918 1466-1484 NN denotes osteoclastogenesis
T14917 1452-1465 JJ denotes RANKL-induced
T14916 1449-1451 IN denotes of
T14915 1438-1448 NNS denotes conditions
T14914 1432-1437 IN denotes under
T14913 1420-1431 VBN denotes upregulated
T14912 1411-1419 RB denotes markedly
T14911 1408-1410 VBZ denotes is
T14910 1397-1407 NN denotes expression
T14909 1392-1396 NNP denotes CYLD
T14908 1390-1391 . denotes .
T14907 1379-1390 NNS denotes osteoclasts
T14906 1372-1378 JJR denotes larger
T14905 1368-1371 CC denotes and
T14904 1363-1367 JJR denotes more
T14903 1355-1362 VB denotes produce
T14902 1351-1354 CC denotes and
T14901 1335-1350 NN denotes differentiation
T14900 1321-1334 JJ denotes RANKL-induced
T14899 1318-1320 TO denotes to
T14898 1301-1317 JJ denotes hyper-responsive
T14897 1297-1300 VBP denotes are
T14896 1292-1296 NNS denotes mice
T14895 1286-1291 DT denotes these
T14894 1283-1285 IN denotes of
T14893 1272-1282 NNS denotes precursors
T14832 895-896 , denotes ,
T14831 885-895 NN denotes signalling
T14830 879-884 JJ denotes NF-κB
T14829 876-878 IN denotes of
T14828 869-875 NNS denotes phases
T14827 863-868 RB denotes later
T14826 853-862 VBZ denotes regulates
T14825 846-852 RB denotes mainly
T14824 838-845 NN denotes protein
T14823 833-837 DT denotes this
T14822 828-832 IN denotes that
T14821 818-827 VBN denotes suggested
T14820 813-817 VBN denotes been
T14819 809-812 VBZ denotes has
T14818 806-808 PRP denotes it
T14817 804-805 , denotes ,
T14816 793-804 NN denotes stimulation
T14815 788-792 IN denotes upon
T14814 782-787 NNS denotes types
T14813 777-781 NN denotes cell
T14812 772-776 JJ denotes many
T14811 769-771 IN denotes in
T14810 759-768 VBN denotes expressed
T14809 754-758 RB denotes only
T14808 751-753 VBZ denotes is
T14807 747-750 NNP denotes A20
T14806 744-746 IN denotes As
T14805 742-743 . denotes .
T14804 732-742 NN denotes activation
T14803 726-731 JJ denotes NF-κB
T14802 718-725 VB denotes control
T14801 715-717 TO denotes to
T14800 710-714 NNP denotes CYLD
T14799 707-709 IN denotes as
T14798 702-706 RB denotes well
T14797 699-701 RB denotes as
T14796 695-698 NNP denotes A20
T14795 689-694 VBZ denotes needs
T14794 684-688 NN denotes cell
T14793 680-683 DT denotes the
T14792 676-679 WRB denotes why
T14791 670-675 JJ denotes clear
T14790 666-669 RB denotes not
T14789 660-665 RB denotes still
T14788 657-659 VBZ denotes is
T14787 654-656 PRP denotes it
T14786 650-653 CC denotes and
T14785 646-649 NNP denotes A20
T14784 643-645 IN denotes by
T14783 634-642 VBN denotes targeted
T14782 629-633 RB denotes also
T14781 625-628 VBP denotes are
T14780 619-624 DT denotes these
T14779 616-618 IN denotes of
T14778 611-615 JJ denotes Many
T14777 609-610 . denotes .
T14776 605-609 NNP denotes TAK1
T14775 601-604 CC denotes and
T14774 596-600 NNP denotes RIP1
T14773 594-595 , denotes ,
T14772 589-594 NNP denotes TRAF7
T14771 587-588 , denotes ,
T14770 582-587 NNP denotes TRAF6
T14769 580-581 , denotes ,
T14768 575-580 NNP denotes TRAF2
T14767 573-574 , denotes ,
T14766 569-573 NNP denotes NEMO
T14765 559-568 VBG denotes including
T14764 550-558 NNS denotes proteins
T14763 539-549 VBG denotes signalling
T14762 533-538 NN denotes NF-κB
T14761 525-532 JJ denotes several
T14760 507-524 JJ denotes deubiquitina-ting
T14759 504-506 IN denotes by
T14758 502-503 , denotes ,
T14757 501-502 -RRB- denotes )
T14756 500-501 CD denotes 1
T14755 493-499 NN denotes Figure
T14754 492-493 -LRB- denotes (
T14753 490-491 -RRB- denotes )
T14752 489-490 NNP denotes ]
T14751 487-489 CD denotes 64
T14750 486-487 NNP denotes [
T14749 483-485 IN denotes in
T14748 474-482 VBN denotes reviewed
T14747 473-474 -LRB- denotes (
T14746 461-472 NN denotes stimulation
T14745 452-460 NN denotes receptor
T14744 445-451 NNP denotes T-cell
T14743 441-444 CC denotes and
T14742 436-440 NNP denotes RANK
T14741 434-435 , denotes ,
T14740 430-434 NNP denotes TNFR
T14739 427-429 IN denotes by
T14738 417-426 VBN denotes initiated
T14737 406-416 VBG denotes signalling
T14736 400-405 JJ denotes NF-κB
T14735 390-399 VBZ denotes regulates
T14734 379-389 RB denotes negatively
T14733 374-378 IN denotes that
T14732 367-373 NN denotes enzyme
T14731 350-366 VBG denotes deubiquitinating
T14730 348-349 DT denotes a
T14729 345-347 VBZ denotes is
T14728 340-344 NNP denotes CYLD
T14727 338-339 . denotes .
T14726 337-338 -RRB- denotes )
T14725 336-337 NNP denotes ]
T14724 334-336 CD denotes 64
T14723 333-334 NNP denotes [
T14722 330-332 IN denotes in
T14721 321-329 VBN denotes reviewed
T14720 320-321 -LRB- denotes (
T14719 301-319 NN denotes osteoclastogenesis
T14718 297-300 CC denotes and
T14717 295-296 , denotes ,
T14716 280-295 NN denotes spermatogenesis
T14715 278-279 , denotes ,
T14714 267-278 NN denotes progression
T14713 261-266 NN denotes cycle
T14712 256-260 NN denotes cell
T14711 253-255 TO denotes to
T14710 240-252 NN denotes inflammation
T14709 236-239 CC denotes and
T14708 227-235 NN denotes immunity
T14707 222-226 IN denotes from
T14706 214-221 VBG denotes ranging
T14705 204-213 NNS denotes processes
T14704 190-203 JJ denotes physiological
T14703 182-189 JJ denotes diverse
T14702 179-181 IN denotes in
T14701 177-178 , denotes ,
T14700 170-177 RB denotes however
T14699 168-169 , denotes ,
T14698 160-168 VBN denotes involved
T14697 155-159 RB denotes also
T14696 152-154 VBZ denotes is
T14695 147-151 NNP denotes CYLD
T14694 145-146 . denotes .
T14693 144-145 NNP denotes ]
T14692 142-144 CD denotes 63
T14691 141-142 NNP denotes [
T14690 125-140 NN denotes cylindromatosis
T14689 116-124 JJ denotes familial
T14688 113-115 IN denotes in
T14687 104-112 VBN denotes involved
T14686 93-103 NN denotes suppressor
T14685 86-92 NN denotes tumour
T14684 84-85 DT denotes a
T14683 81-83 IN denotes as
T14682 70-80 VBN denotes identified
T14681 59-69 RB denotes originally
T14680 55-58 VBD denotes was
T14679 47-54 NN denotes protein
T14678 45-46 -RRB- denotes )
T14677 41-45 NNP denotes CYLD
T14676 40-41 -LRB- denotes (
T14675 24-39 NNP denotes Cylindromatosis
T14674 16-23 NN denotes protein
T14673 0-15 NNP denotes Cylindromatosis
T14892 1261-1271 NNP denotes Osteoclast
T14891 1259-1260 . denotes .
T14890 1247-1259 NN denotes osteoporosis
T14889 1240-1246 JJ denotes severe
T14888 1232-1239 VB denotes develop
T14887 1228-1231 CC denotes and
T14886 1212-1227 NN denotes differentiation
T14885 1201-1211 NN denotes osteoclast
T14884 1192-1200 JJ denotes aberrant
T14883 1187-1191 VBP denotes have
T14882 1182-1186 NNP denotes CYLD
T14881 1179-1181 IN denotes of
T14880 1168-1178 NN denotes deficiency
T14879 1160-1167 JJ denotes genetic
T14878 1158-1159 DT denotes a
T14877 1153-1157 IN denotes with
T14876 1148-1152 NN denotes Mice
T14875 1146-1147 . denotes .
T14874 1145-1146 NNP denotes ]
T14873 1143-1145 CD denotes 65
T14872 1142-1143 NNP denotes [
T14871 1137-1141 NNS denotes mice
T14870 1134-1136 IN denotes in
T14869 1115-1133 NN denotes osteoclastogenesis
T14868 1111-1114 CC denotes and
T14867 1100-1110 NN denotes signalling
T14866 1095-1099 NNP denotes RANK
T14865 1086-1094 VB denotes regulate
T14864 1075-1085 RB denotes negatively
T14863 1072-1074 TO denotes to
T14862 1066-1071 VBN denotes shown
T14861 1061-1065 VBN denotes been
T14860 1057-1060 VBZ denotes has
T14859 1052-1056 NNP denotes CYLD
T14858 1050-1051 , denotes ,
T14857 1037-1050 RB denotes Interestingly
T14856 1035-1036 . denotes .
T14855 1034-1035 NNP denotes ]
T14854 1032-1034 CD denotes 64
T14853 1031-1032 NNP denotes [
T14852 1021-1030 JJ denotes dependent
T14851 1011-1020 JJ denotes cell-type
T14850 1008-1010 VB denotes be
T14849 1003-1007 RB denotes also
T14848 997-1002 MD denotes might
T14847 988-996 NN denotes activity
T14846 979-987 JJ denotes relative
T14845 973-978 PRP$ denotes their
T14844 971-972 , denotes ,
T14843 963-971 NN denotes addition
T14842 960-962 IN denotes In
T14841 958-959 . denotes .
T14840 948-958 NN denotes signalling
T14839 942-947 JJ denotes early
T14838 938-941 CC denotes and
T14837 925-937 JJ denotes constitutive
T14836 916-924 VB denotes regulate
T14835 910-915 MD denotes would
T14834 905-909 NNP denotes CYLD
T14833 897-904 IN denotes whereas
R9695 T14673 T14675 compound Cylindromatosis,Cylindromatosis
R9696 T14674 T14675 compound protein,Cylindromatosis
R9697 T14675 T14682 nsubjpass Cylindromatosis,identified
R9698 T14676 T14677 punct (,CYLD
R9699 T14677 T14675 appos CYLD,Cylindromatosis
R9700 T14678 T14677 punct ),CYLD
R9701 T14679 T14682 nsubjpass protein,identified
R9702 T14680 T14682 auxpass was,identified
R9703 T14681 T14682 advmod originally,identified
R9704 T14682 T14682 ROOT identified,identified
R9705 T14683 T14682 prep as,identified
R9706 T14684 T14686 det a,suppressor
R9707 T14685 T14686 compound tumour,suppressor
R9708 T14686 T14683 pobj suppressor,as
R9709 T14687 T14686 acl involved,suppressor
R9710 T14688 T14687 prep in,involved
R9711 T14689 T14690 amod familial,cylindromatosis
R9712 T14690 T14691 compound cylindromatosis,[
R9713 T14691 T14688 pobj [,in
R9714 T14692 T14693 nummod 63,]
R9715 T14693 T14691 appos ],[
R9716 T14694 T14682 punct .,identified
R9717 T14695 T14698 nsubjpass CYLD,involved
R9718 T14696 T14698 auxpass is,involved
R9719 T14697 T14698 advmod also,involved
R9720 T14698 T14721 ccomp involved,reviewed
R9721 T14699 T14721 punct ",",reviewed
R9722 T14700 T14721 advmod however,reviewed
R9723 T14701 T14721 punct ",",reviewed
R9724 T14702 T14721 prep in,reviewed
R9725 T14703 T14705 amod diverse,processes
R9726 T14704 T14705 amod physiological,processes
R9727 T14705 T14702 pobj processes,in
R9728 T14706 T14705 acl ranging,processes
R9729 T14707 T14706 prep from,ranging
R9730 T14708 T14707 pobj immunity,from
R9731 T14709 T14708 cc and,immunity
R9732 T14710 T14708 conj inflammation,immunity
R9733 T14711 T14721 prep to,reviewed
R9734 T14712 T14713 compound cell,cycle
R9735 T14713 T14714 compound cycle,progression
R9736 T14714 T14711 pobj progression,to
R9737 T14715 T14714 punct ",",progression
R9738 T14716 T14714 conj spermatogenesis,progression
R9739 T14717 T14716 punct ",",spermatogenesis
R9740 T14718 T14716 cc and,spermatogenesis
R9741 T14719 T14716 conj osteoclastogenesis,spermatogenesis
R9742 T14720 T14721 punct (,reviewed
R9743 T14721 T14721 ROOT reviewed,reviewed
R9744 T14722 T14721 prep in,reviewed
R9745 T14723 T14722 pobj [,in
R9746 T14724 T14725 nummod 64,]
R9747 T14725 T14723 appos ],[
R9748 T14726 T14723 punct ),[
R9749 T14727 T14721 punct .,reviewed
R9750 T14728 T14729 nsubj CYLD,is
R9751 T14729 T14729 ROOT is,is
R9752 T14730 T14732 det a,enzyme
R9753 T14731 T14732 amod deubiquitinating,enzyme
R9754 T14732 T14729 attr enzyme,is
R9755 T14733 T14735 nsubj that,regulates
R9756 T14734 T14735 advmod negatively,regulates
R9757 T14735 T14732 relcl regulates,enzyme
R9758 T14736 T14737 amod NF-κB,signalling
R9759 T14737 T14735 xcomp signalling,regulates
R9760 T14738 T14737 acl initiated,signalling
R9761 T14739 T14738 agent by,initiated
R9762 T14740 T14739 pobj TNFR,by
R9763 T14741 T14740 punct ",",TNFR
R9764 T14742 T14740 conj RANK,TNFR
R9765 T14743 T14742 cc and,RANK
R9766 T14744 T14742 conj T-cell,RANK
R9767 T14745 T14746 compound receptor,stimulation
R9768 T14746 T14740 appos stimulation,TNFR
R9769 T14747 T14748 punct (,reviewed
R9770 T14748 T14737 acl reviewed,signalling
R9771 T14749 T14748 prep in,reviewed
R9772 T14750 T14749 pobj [,in
R9773 T14751 T14752 nummod 64,]
R9774 T14752 T14750 appos ],[
R9775 T14753 T14750 punct ),[
R9776 T14754 T14755 punct (,Figure
R9777 T14755 T14748 appos Figure,reviewed
R9778 T14756 T14755 nummod 1,Figure
R9779 T14757 T14755 punct ),Figure
R9780 T14758 T14755 punct ",",Figure
R9781 T14759 T14755 prep by,Figure
R9782 T14760 T14764 amod deubiquitina-ting,proteins
R9783 T14761 T14764 amod several,proteins
R9784 T14762 T14763 npadvmod NF-κB,signalling
R9785 T14763 T14764 amod signalling,proteins
R9786 T14764 T14759 pobj proteins,by
R9787 T14765 T14764 prep including,proteins
R9788 T14766 T14765 pobj NEMO,including
R9789 T14767 T14766 punct ",",NEMO
R9790 T14768 T14766 conj TRAF2,NEMO
R9791 T14769 T14768 punct ",",TRAF2
R9792 T14770 T14768 conj TRAF6,TRAF2
R9793 T14771 T14770 punct ",",TRAF6
R9794 T14772 T14770 conj TRAF7,TRAF6
R9795 T14773 T14772 punct ",",TRAF7
R9796 T14774 T14772 conj RIP1,TRAF7
R9797 T14775 T14774 cc and,RIP1
R9798 T14776 T14774 conj TAK1,RIP1
R9799 T14777 T14755 punct .,Figure
R9800 T14778 T14783 nsubjpass Many,targeted
R9801 T14779 T14778 prep of,Many
R9802 T14780 T14779 pobj these,of
R9803 T14781 T14783 auxpass are,targeted
R9804 T14782 T14783 advmod also,targeted
R9805 T14783 T14783 ROOT targeted,targeted
R9806 T14784 T14783 agent by,targeted
R9807 T14785 T14784 pobj A20,by
R9808 T14786 T14783 cc and,targeted
R9809 T14787 T14788 nsubj it,is
R9810 T14788 T14783 conj is,targeted
R9811 T14789 T14788 advmod still,is
R9812 T14790 T14788 neg not,is
R9813 T14791 T14788 acomp clear,is
R9814 T14792 T14795 advmod why,needs
R9815 T14793 T14794 det the,cell
R9816 T14794 T14795 nsubj cell,needs
R9817 T14795 T14788 ccomp needs,is
R9818 T14796 T14802 nsubj A20,control
R9819 T14797 T14799 advmod as,as
R9820 T14798 T14799 advmod well,as
R9821 T14799 T14796 cc as,A20
R9822 T14800 T14796 conj CYLD,A20
R9823 T14801 T14802 aux to,control
R9824 T14802 T14795 ccomp control,needs
R9825 T14803 T14804 amod NF-κB,activation
R9826 T14804 T14802 dobj activation,control
R9827 T14805 T14788 punct .,is
R9828 T14806 T14810 mark As,expressed
R9829 T14807 T14810 nsubjpass A20,expressed
R9830 T14808 T14810 auxpass is,expressed
R9831 T14809 T14810 advmod only,expressed
R9832 T14810 T14821 advcl expressed,suggested
R9833 T14811 T14810 prep in,expressed
R9834 T14812 T14814 amod many,types
R9835 T14813 T14814 compound cell,types
R9836 T14814 T14811 pobj types,in
R9837 T14815 T14810 prep upon,expressed
R9838 T14816 T14815 pobj stimulation,upon
R9839 T14817 T14821 punct ",",suggested
R9840 T14818 T14821 nsubjpass it,suggested
R9841 T14819 T14821 aux has,suggested
R9842 T14820 T14821 auxpass been,suggested
R9843 T14821 T14821 ROOT suggested,suggested
R9844 T14822 T14826 mark that,regulates
R9845 T14823 T14824 det this,protein
R9846 T14824 T14826 nsubj protein,regulates
R9847 T14825 T14826 advmod mainly,regulates
R9848 T14826 T14821 ccomp regulates,suggested
R9849 T14827 T14828 amod later,phases
R9850 T14828 T14826 dobj phases,regulates
R9851 T14829 T14828 prep of,phases
R9852 T14830 T14831 amod NF-κB,signalling
R9853 T14831 T14829 pobj signalling,of
R9854 T14832 T14826 punct ",",regulates
R9855 T14833 T14836 mark whereas,regulate
R9856 T14834 T14836 nsubj CYLD,regulate
R9857 T14835 T14836 aux would,regulate
R9858 T14836 T14826 advcl regulate,regulates
R9859 T14837 T14836 dobj constitutive,regulate
R9860 T14838 T14837 cc and,constitutive
R9861 T14839 T14840 amod early,signalling
R9862 T14840 T14837 conj signalling,constitutive
R9863 T14841 T14821 punct .,suggested
R9864 T14842 T14850 prep In,be
R9865 T14843 T14842 pobj addition,In
R9866 T14844 T14850 punct ",",be
R9867 T14845 T14847 poss their,activity
R9868 T14846 T14847 amod relative,activity
R9869 T14847 T14850 nsubj activity,be
R9870 T14848 T14850 aux might,be
R9871 T14849 T14850 advmod also,be
R9872 T14850 T14850 ROOT be,be
R9873 T14851 T14852 npadvmod cell-type,dependent
R9874 T14852 T14855 amod dependent,]
R9875 T14853 T14855 nmod [,]
R9876 T14854 T14855 nummod 64,]
R9877 T14855 T14850 attr ],be
R9878 T14856 T14850 punct .,be
R9879 T14857 T14862 advmod Interestingly,shown
R9880 T14858 T14862 punct ",",shown
R9881 T14859 T14862 nsubjpass CYLD,shown
R9882 T14860 T14862 aux has,shown
R9883 T14861 T14862 auxpass been,shown
R9884 T14862 T14862 ROOT shown,shown
R9885 T14863 T14865 aux to,regulate
R9886 T14864 T14865 advmod negatively,regulate
R9887 T14865 T14862 xcomp regulate,shown
R9888 T14866 T14867 compound RANK,signalling
R9889 T14867 T14865 dobj signalling,regulate
R9890 T14868 T14867 cc and,signalling
R9891 T14869 T14867 conj osteoclastogenesis,signalling
R9892 T14870 T14867 prep in,signalling
R9893 T14871 T14870 pobj mice,in
R9894 T14872 T14874 nmod [,]
R9895 T14873 T14874 nummod 65,]
R9896 T14874 T14867 appos ],signalling
R9897 T14875 T14862 punct .,shown
R9898 T14876 T14883 nsubj Mice,have
R9899 T14877 T14876 prep with,Mice
R9900 T14878 T14880 det a,deficiency
R9901 T14879 T14880 amod genetic,deficiency
R9902 T14880 T14877 pobj deficiency,with
R9903 T14881 T14880 prep of,deficiency
R9904 T14882 T14881 pobj CYLD,of
R9905 T14883 T14883 ROOT have,have
R9906 T14884 T14886 amod aberrant,differentiation
R9907 T14885 T14886 compound osteoclast,differentiation
R9908 T14886 T14883 dobj differentiation,have
R9909 T14887 T14883 cc and,have
R9910 T14888 T14883 conj develop,have
R9911 T14889 T14890 amod severe,osteoporosis
R9912 T14890 T14888 dobj osteoporosis,develop
R9913 T14891 T14883 punct .,have
R9914 T14892 T14897 dep Osteoclast,are
R9915 T14893 T14897 nsubj precursors,are
R9916 T14894 T14893 prep of,precursors
R9917 T14895 T14896 det these,mice
R9918 T14896 T14894 pobj mice,of
R9919 T14897 T14897 ROOT are,are
R9920 T14898 T14897 acomp hyper-responsive,are
R9921 T14899 T14898 prep to,hyper-responsive
R9922 T14900 T14901 amod RANKL-induced,differentiation
R9923 T14901 T14899 pobj differentiation,to
R9924 T14902 T14897 cc and,are
R9925 T14903 T14897 conj produce,are
R9926 T14904 T14907 amod more,osteoclasts
R9927 T14905 T14904 cc and,more
R9928 T14906 T14904 conj larger,more
R9929 T14907 T14903 dobj osteoclasts,produce
R9930 T14908 T14897 punct .,are
R9931 T14909 T14910 compound CYLD,expression
R9932 T14910 T14913 nsubjpass expression,upregulated
R9933 T14911 T14913 auxpass is,upregulated
R9934 T14912 T14913 advmod markedly,upregulated
R9935 T14913 T14913 ROOT upregulated,upregulated
R9936 T14914 T14913 prep under,upregulated
R9937 T14915 T14914 pobj conditions,under
R9938 T14916 T14915 prep of,conditions
R9939 T14917 T14918 compound RANKL-induced,osteoclastogenesis
R9940 T14918 T14916 pobj osteoclastogenesis,of
R9941 T14919 T14913 cc and,upregulated
R9942 T14920 T14921 auxpass is,recruited
R9943 T14921 T14913 conj recruited,upregulated
R9944 T14922 T14921 prep to,recruited
R9945 T14923 T14924 amod ubiquitinated,TRAF6
R9946 T14924 T14922 pobj TRAF6,to
R9947 T14925 T14921 prep via,recruited
R9948 T14926 T14929 det the,protein
R9949 T14927 T14929 amod ubiquitin-binding,protein
R9955 T14933 T14930 acl known,p62
R9956 T14934 T14933 prep as,known
R9957 T14935 T14934 pobj sequestosome,as
R9958 T14936 T14935 nummod 1,sequestosome
R9959 T14937 T14930 punct ),p62
R9960 T14938 T14940 nmod [,]
R9961 T14939 T14940 nummod 65,]
R9962 T14940 T14940 ROOT ],]
R9963 T14941 T14940 punct ",",]
R9964 T14942 T14940 acl followed,]
R9965 T14943 T14942 agent by,followed
R9966 T14944 T14946 det the,deubiquitination
R9967 T14945 T14946 amod CYLD-mediated,deubiquitination
R9968 T14946 T14943 pobj deubiquitination,by
R9969 T14947 T14946 prep of,deubiquitination
R9970 T14948 T14947 pobj TRAF6,of
R9971 T14949 T14913 punct .,upregulated
R9972 T14950 T14955 prep In,is
R9973 T14951 T14952 det this,context
R9974 T14952 T14950 pobj context,In
R9975 T14953 T14955 punct ",",is
R9976 T14954 T14955 nsubj it,is
R9977 T14955 T14955 ROOT is,is
R9978 T14956 T14955 acomp worth,is
R9979 T14957 T14956 xcomp mentioning,worth
R9980 T14958 T14968 mark that,display
R9981 T14959 T14960 amod transgenic,mice
R9982 T14960 T14968 nsubj mice,display
R9983 T14961 T14960 acl expressing,mice
R9984 T14962 T14964 det a,form
R9985 T14963 T14964 amod mutated,form
R9986 T14964 T14961 dobj form,expressing
R9987 T14965 T14964 prep of,form
R9988 T14966 T14965 pobj p62,of
R9989 T14967 T14968 advmod also,display
R9990 T14968 T14955 ccomp display,is
R9991 T14969 T14970 amod abnormal,osteoclastogenesis
R9992 T14970 T14968 dobj osteoclastogenesis,display
R9993 T14971 T14968 cc and,display
R9994 T14972 T14968 conj develop,display
R9995 T14973 T14975 amod progressive,loss
R9996 T14974 T14975 compound bone,loss
R9997 T14975 T14972 dobj loss,develop
R9998 T14976 T14978 nmod [,]
R9999 T14977 T14978 nummod 66,]
R10000 T14978 T14975 appos ],loss
R10001 T14979 T14955 punct .,is
R10002 T14980 T14981 det These,findings
R10003 T14981 T14982 nsubj findings,suggest
R10004 T14982 T14982 ROOT suggest,suggest
R10005 T14983 T15001 mark that,indicate
R10006 T14984 T14985 amod CYLD-mediated,inhibi-tion
R10007 T14985 T15001 nsubj inhibi-tion,indicate
R10008 T14986 T14985 prep of,inhibi-tion
R10009 T14987 T14988 amod RANK-induced,NF-κB
R10010 T14988 T14989 nsubj NF-κB,signalling
R10011 T14989 T14986 pcomp signalling,of
R10012 T14990 T14989 dobj plays,signalling
R10013 T14991 T14993 det a,role
R10014 T14992 T14993 amod key,role
R10015 T14993 T14989 oprd role,signalling
R10016 T14994 T14993 prep in,role
R10017 T14995 T14997 det the,regulation
R10018 T14996 T14997 amod negative,regulation
R10019 T14997 T14994 pobj regulation,in
R10020 T14998 T14997 prep of,regulation
R10021 T14999 T14998 pobj osteoclastogenesis,of
R10022 T15000 T14989 cc and,signalling
R10023 T15001 T14982 ccomp indicate,suggest
R10029 T15007 T15003 pobj factor,as
R10030 T15008 T15007 acl involved,factor
R10031 T15009 T15008 prep in,involved
R10032 T15010 T15011 det the,pathology
R10033 T15011 T15009 pobj pathology,in
R10034 T15012 T15011 prep of,pathology
R10035 T15013 T15014 compound bone,disorders
R10036 T15014 T15012 pobj disorders,of
R10037 T15015 T15016 amod such,as
R10038 T15016 T15014 prep as,disorders
R10039 T15017 T15016 pobj RA,as
R10040 T15018 T14982 punct .,suggest
R9950 T14928 T14929 compound adaptor,protein
R9951 T14929 T14925 pobj protein,via
R9952 T14930 T14921 conj p62,recruited
R9953 T14931 T14933 punct (,known
R9954 T14932 T14933 advmod also,known
R10024 T15002 T15001 dobj CYLD,indicate
R10025 T15003 T15001 prep as,indicate
R10026 T15004 T15007 det a,factor
R10027 T15005 T15007 amod potential,factor
R10028 T15006 T15007 amod genetic,factor

DLUT931

Id Subject Object Predicate Lexical cue
T15108 1397-1407 Gene_expression denotes expression
T15107 1168-1178 Negative_regulation denotes deficiency
T15106 759-768 Gene_expression denotes expressed
T15105 2006-2010 Protein denotes CYLD
T15104 1897-1901 Protein denotes RANK
T15103 1868-1872 Protein denotes CYLD
T15102 1755-1758 Protein denotes p62
T15101 1658-1663 Protein denotes TRAF6
T15100 1624-1628 Protein denotes CYLD
T15099 1586-1600 Protein denotes sequestosome 1
T15098 1567-1570 Protein denotes p62
T15097 1533-1542 Protein denotes ubiquitin
T15096 1519-1524 Protein denotes TRAF6
T15095 1452-1457 Protein denotes RANKL
T15094 1392-1396 Protein denotes CYLD
T15093 1321-1326 Protein denotes RANKL
T15092 1182-1186 Protein denotes CYLD
T15091 1095-1099 Protein denotes RANK
T15090 1052-1056 Protein denotes CYLD
T15089 905-909 Protein denotes CYLD
T15088 747-750 Protein denotes A20
T15087 710-714 Protein denotes CYLD
T15086 695-698 Protein denotes A20
T15085 646-649 Protein denotes A20
T15084 575-580 Protein denotes TRAF2
T15083 569-573 Protein denotes NEMO
T15082 436-440 Protein denotes RANK
T15081 350-373 Protein denotes deubiquitinating enzyme
T15080 340-344 Protein denotes CYLD
T15079 605-609 Protein denotes TAK1
T15078 596-600 Protein denotes RIP1
T15077 589-594 Protein denotes TRAF7
T15076 582-587 Protein denotes TRAF6
T15075 147-151 Protein denotes CYLD
T15074 41-45 Protein denotes CYLD
T15073 24-39 Protein denotes Cylindromatosis
T15072 0-15 Protein denotes Cylindromatosis
T15114 1726-1736 Gene_expression denotes expressing
T15113 1638-1654 Negative_regulation denotes deubiquitination
T15112 1543-1550 Binding denotes binding
T15111 1505-1518 Positive_regulation denotes ubiquitinated
T15110 1492-1501 Binding denotes recruited
T15109 1420-1431 Positive_regulation denotes upregulated
R10051 T15088 T15106 themeOf A20,expressed
R10052 T15092 T15107 themeOf CYLD,deficiency
R10053 T15094 T15108 themeOf CYLD,expression
R10054 T15096 T15110 themeOf TRAF6,recruited
R10055 T15096 T15111 themeOf TRAF6,ubiquitinated
R10056 T15097 T15112 themeOf ubiquitin,binding
R10057 T15098 T15110 themeOf p62,recruited
R10058 T15098 T15112 themeOf p62,binding
R10059 T15101 T15113 themeOf TRAF6,deubiquitination
R10060 T15102 T15114 themeOf p62,expressing
R10061 T15108 T15109 themeOf expression,upregulated

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T15028 1586-1600 http://www.uniprot.org/uniprot/Q13501 denotes sequestosome 1
T15027 747-750 http://www.uniprot.org/uniprot/P21580 denotes A20
T15026 695-698 http://www.uniprot.org/uniprot/P21580 denotes A20
T15025 646-649 http://www.uniprot.org/uniprot/P21580 denotes A20
T15024 596-600 http://www.uniprot.org/uniprot/Q13546 denotes RIP1
T15023 1658-1663 http://www.uniprot.org/uniprot/Q9Y4K3 denotes TRAF6
T15022 1519-1524 http://www.uniprot.org/uniprot/Q9Y4K3 denotes TRAF6
T15021 582-587 http://www.uniprot.org/uniprot/Q9Y4K3 denotes TRAF6
T15020 575-580 http://www.uniprot.org/uniprot/Q12933 denotes TRAF2
T15019 569-573 http://www.uniprot.org/uniprot/Q9Y6K9 denotes NEMO

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T14243 2006-2010 Protein denotes CYLD
T14242 1897-1901 Protein denotes RANK
T14241 1868-1872 Protein denotes CYLD
T14240 1755-1758 Protein denotes p62
T14239 1658-1663 Protein denotes TRAF6
T14238 1624-1628 Protein denotes CYLD
T14237 1586-1600 Protein denotes sequestosome 1
T14236 1567-1570 Protein denotes p62
T14235 1533-1542 Protein denotes ubiquitin
T14234 1519-1524 Protein denotes TRAF6
T14233 1452-1457 Protein denotes RANKL
T14232 1392-1396 Protein denotes CYLD
T14231 1321-1326 Protein denotes RANKL
T14230 1182-1186 Protein denotes CYLD
T14229 1095-1099 Protein denotes RANK
T14228 1052-1056 Protein denotes CYLD
T14227 905-909 Protein denotes CYLD
T14226 747-750 Protein denotes A20
T14225 710-714 Protein denotes CYLD
T14224 695-698 Protein denotes A20
T14223 646-649 Protein denotes A20
T14222 605-609 Protein denotes TAK1
T14221 596-600 Protein denotes RIP1
T14220 589-594 Protein denotes TRAF7
T14219 582-587 Protein denotes TRAF6
T14218 575-580 Protein denotes TRAF2
T14217 569-573 Protein denotes NEMO
T14216 436-440 Protein denotes RANK
T14215 350-373 Protein denotes deubiquitinating enzyme
T14214 340-344 Protein denotes CYLD
T14213 147-151 Protein denotes CYLD
T14212 41-45 Protein denotes CYLD
T14211 24-39 Protein denotes Cylindromatosis
T14210 0-15 Protein denotes Cylindromatosis

bionlp-st-ge-2016-coref

Id Subject Object Predicate Lexical cue
T14209 605-609 Antecedent denotes TAK1
T14208 596-600 Antecedent denotes RIP1
T14207 589-594 Antecedent denotes TRAF7
T14206 582-587 Antecedent denotes TRAF6
T14205 575-580 Antecedent denotes TRAF2
T14204 569-573 Antecedent denotes NEMO
T14203 619-624 Anaphor denotes these
R9341 T14203 T14204 boundBy these,NEMO
R9342 T14203 T14205 boundBy these,TRAF2
R9343 T14203 T14206 boundBy these,TRAF6
R9344 T14203 T14207 boundBy these,TRAF7
R9345 T14203 T14208 boundBy these,RIP1
R9346 T14203 T14209 boundBy these,TAK1

2_test

Id Subject Object Predicate Lexical cue
21639951-10835629-4289491 142-144 10835629 denotes 63
21639951-19373246-4289492 334-336 19373246 denotes 64
21639951-19373246-4289493 487-489 19373246 denotes 64
21639951-19373246-4289494 1032-1034 19373246 denotes 64
21639951-18382763-4289495 1143-1145 18382763 denotes 65
21639951-18382763-4289496 1603-1605 18382763 denotes 65
21639951-17187080-4289497 1835-1837 17187080 denotes 66

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T14577 2093-2095 NN denotes RA
T14576 2090-2092 IN denotes as
T14575 2085-2089 JJ denotes such
T14574 2075-2084 NN denotes disorders
T14573 2070-2074 NN denotes bone
T14572 2067-2069 IN denotes of
T14571 2057-2066 NN denotes pathology
T14570 2053-2056 DT denotes the
T14569 2050-2052 IN denotes in
T14568 2041-2049 VB denotes involved
T14567 2034-2040 NN denotes factor
T14566 2026-2033 JJ denotes genetic
T14565 2016-2025 JJ denotes potential
T14564 2014-2015 DT denotes a
T14563 2011-2013 IN denotes as
T14562 2006-2010 NN denotes CYLD
T14561 1997-2005 VB denotes indicate
T14560 1993-1996 CC denotes and
T14559 1974-1992 NN denotes osteoclastogenesis
T14558 1971-1973 IN denotes of
T14557 1960-1970 NN denotes regulation
T14556 1951-1959 JJ denotes negative
T14555 1947-1950 DT denotes the
T14554 1944-1946 IN denotes in
T14553 1939-1943 NN denotes role
T14552 1935-1938 JJ denotes key
T14551 1933-1934 DT denotes a
T14550 1927-1932 VB denotes plays
T14549 1916-1926 NN denotes signalling
T14548 1910-1915 NN denotes NF-κB
T14547 1897-1909 JJ denotes RANK-induced
T14546 1894-1896 IN denotes of
T14545 1882-1893 NN denotes inhibi-tion
T14544 1868-1881 JJ denotes CYLD-mediated
T14543 1863-1867 IN denotes that
T14542 1855-1862 VB denotes suggest
T14541 1846-1854 NN denotes findings
T14540 1840-1845 DT denotes These
T14539 1837-1838 -RRB- denotes ]
T14538 1835-1837 CD denotes 66
T14537 1834-1835 -LRB- denotes [
T14536 1829-1833 NN denotes loss
T14535 1824-1828 NN denotes bone
T14534 1812-1823 JJ denotes progressive
T14533 1804-1811 VB denotes develop
T14532 1800-1803 CC denotes and
T14531 1781-1799 NN denotes osteoclastogenesis
T14530 1772-1780 JJ denotes abnormal
T14529 1764-1771 VB denotes display
T14528 1759-1763 RB denotes also
T14527 1755-1758 NN denotes p62
T14526 1752-1754 IN denotes of
T14525 1747-1751 NN denotes form
T14524 1739-1746 VB denotes mutated
T14523 1737-1738 DT denotes a
T14522 1726-1736 VB denotes expressing
T14521 1721-1725 NN denotes mice
T14520 1710-1720 JJ denotes transgenic
T14519 1705-1709 IN denotes that
T14518 1694-1704 VB denotes mentioning
T14517 1688-1693 JJ denotes worth
T14516 1685-1687 VB denotes is
T14515 1682-1684 PRP denotes it
T14514 1680-1681 -COMMA- denotes ,
T14513 1673-1680 NN denotes context
T14512 1668-1672 DT denotes this
T14511 1665-1667 IN denotes In
T14510 1658-1663 NN denotes TRAF6
T14509 1655-1657 IN denotes of
T14508 1638-1654 NN denotes deubiquitination
T14507 1624-1637 JJ denotes CYLD-mediated
T14506 1620-1623 DT denotes the
T14505 1617-1619 IN denotes by
T14504 1608-1616 VB denotes followed
T14503 1606-1607 -COMMA- denotes ,
T14502 1605-1606 -RRB- denotes ]
T14501 1603-1605 CD denotes 65
T14500 1602-1603 -LRB- denotes [
T14499 1600-1601 -RRB- denotes )
T14498 1599-1600 CD denotes 1
T14497 1586-1598 NN denotes sequestosome
T14496 1583-1585 IN denotes as
T14495 1577-1582 VB denotes known
T14494 1572-1576 RB denotes also
T14493 1571-1572 -LRB- denotes (
T14492 1567-1570 NN denotes p62
T14491 1559-1566 NN denotes protein
T14490 1551-1558 NN denotes adaptor
T14489 1533-1550 JJ denotes ubiquitin-binding
T14488 1529-1532 DT denotes the
T14487 1525-1528 IN denotes via
T14486 1519-1524 NN denotes TRAF6
T14485 1505-1518 VB denotes ubiquitinated
T14484 1502-1504 TO denotes to
T14483 1492-1501 VB denotes recruited
T14482 1489-1491 VB denotes is
T14481 1485-1488 CC denotes and
T14480 1466-1484 NN denotes osteoclastogenesis
T14479 1452-1465 JJ denotes RANKL-induced
T14478 1449-1451 IN denotes of
T14477 1438-1448 NN denotes conditions
T14476 1432-1437 IN denotes under
T14475 1420-1431 VB denotes upregulated
T14474 1411-1419 RB denotes markedly
T14473 1408-1410 VB denotes is
T14472 1397-1407 NN denotes expression
T14471 1392-1396 NN denotes CYLD
T14470 1379-1390 NN denotes osteoclasts
T14469 1372-1378 JJ denotes larger
T14468 1368-1371 CC denotes and
T14467 1363-1367 JJ denotes more
T14466 1355-1362 VB denotes produce
T14465 1351-1354 CC denotes and
T14464 1335-1350 NN denotes differentiation
T14463 1321-1334 JJ denotes RANKL-induced
T14462 1318-1320 TO denotes to
T14461 1301-1317 JJ denotes hyper-responsive
T14460 1297-1300 VB denotes are
T14459 1292-1296 NN denotes mice
T14458 1286-1291 DT denotes these
T14457 1283-1285 IN denotes of
T14456 1272-1282 NN denotes precursors
T14455 1261-1271 NN denotes Osteoclast
T14454 1247-1259 NN denotes osteoporosis
T14453 1240-1246 JJ denotes severe
T14452 1232-1239 VB denotes develop
T14451 1228-1231 CC denotes and
T14450 1212-1227 NN denotes differentiation
T14449 1201-1211 NN denotes osteoclast
T14448 1192-1200 JJ denotes aberrant
T14447 1187-1191 VB denotes have
T14446 1182-1186 NN denotes CYLD
T14445 1179-1181 IN denotes of
T14444 1168-1178 NN denotes deficiency
T14443 1160-1167 JJ denotes genetic
T14442 1158-1159 DT denotes a
T14441 1153-1157 IN denotes with
T14440 1148-1152 NN denotes Mice
T14439 1145-1146 -RRB- denotes ]
T14438 1143-1145 CD denotes 65
T14437 1142-1143 -LRB- denotes [
T14436 1137-1141 NN denotes mice
T14435 1134-1136 IN denotes in
T14434 1115-1133 NN denotes osteoclastogenesis
T14433 1111-1114 CC denotes and
T14432 1100-1110 NN denotes signalling
T14431 1095-1099 NN denotes RANK
T14430 1086-1094 VB denotes regulate
T14429 1075-1085 RB denotes negatively
T14428 1072-1074 TO denotes to
T14427 1066-1071 VB denotes shown
T14426 1061-1065 VB denotes been
T14425 1057-1060 VB denotes has
T14424 1052-1056 NN denotes CYLD
T14423 1050-1051 -COMMA- denotes ,
T14422 1037-1050 RB denotes Interestingly
T14421 1034-1035 -RRB- denotes ]
T14420 1032-1034 CD denotes 64
T14419 1031-1032 -LRB- denotes [
T14418 1021-1030 JJ denotes dependent
T14417 1011-1020 JJ denotes cell-type
T14416 1008-1010 VB denotes be
T14415 1003-1007 RB denotes also
T14414 997-1002 MD denotes might
T14413 988-996 NN denotes activity
T14265 147-151 NN denotes CYLD
T14264 144-145 -RRB- denotes ]
T14263 142-144 CD denotes 63
T14262 141-142 -LRB- denotes [
T14261 125-140 NN denotes cylindromatosis
T14260 116-124 JJ denotes familial
T14259 113-115 IN denotes in
T14258 104-112 VB denotes involved
T14257 93-103 NN denotes suppressor
T14256 86-92 NN denotes tumour
T14255 84-85 DT denotes a
T14254 81-83 IN denotes as
T14253 70-80 VB denotes identified
T14252 59-69 RB denotes originally
T14251 55-58 VB denotes was
T14250 47-54 NN denotes protein
T14249 45-46 -RRB- denotes )
T14248 41-45 NN denotes CYLD
T14247 40-41 -LRB- denotes (
T14246 24-39 NN denotes Cylindromatosis
T14245 16-23 NN denotes protein
T14244 0-15 NN denotes Cylindromatosis
T14412 979-987 JJ denotes relative
T14411 973-978 PRP-DOLLAR- denotes their
T14410 971-972 -COMMA- denotes ,
T14409 963-971 NN denotes addition
T14408 960-962 IN denotes In
T14407 948-958 NN denotes signalling
T14406 942-947 JJ denotes early
T14405 938-941 CC denotes and
T14404 925-937 JJ denotes constitutive
T14403 916-924 VB denotes regulate
T14402 910-915 MD denotes would
T14401 905-909 NN denotes CYLD
T14400 897-904 IN denotes whereas
T14399 895-896 -COMMA- denotes ,
T14398 885-895 NN denotes signalling
T14397 879-884 NN denotes NF-κB
T14396 876-878 IN denotes of
T14395 869-875 NN denotes phases
T14394 863-868 JJ denotes later
T14393 853-862 VB denotes regulates
T14392 846-852 RB denotes mainly
T14391 838-845 NN denotes protein
T14390 833-837 DT denotes this
T14389 828-832 IN denotes that
T14388 818-827 VB denotes suggested
T14387 813-817 VB denotes been
T14386 809-812 VB denotes has
T14385 806-808 PRP denotes it
T14384 804-805 -COMMA- denotes ,
T14383 793-804 NN denotes stimulation
T14382 788-792 IN denotes upon
T14381 782-787 NN denotes types
T14380 777-781 NN denotes cell
T14379 772-776 JJ denotes many
T14378 769-771 IN denotes in
T14377 759-768 VB denotes expressed
T14376 754-758 RB denotes only
T14375 751-753 VB denotes is
T14374 747-750 NN denotes A20
T14373 744-746 IN denotes As
T14372 732-742 NN denotes activation
T14371 726-731 NN denotes NF-κB
T14370 718-725 VB denotes control
T14369 715-717 TO denotes to
T14368 710-714 NN denotes CYLD
T14367 707-709 IN denotes as
T14366 702-706 RB denotes well
T14365 699-701 RB denotes as
T14364 695-698 NN denotes A20
T14363 689-694 VB denotes needs
T14362 684-688 NN denotes cell
T14361 680-683 DT denotes the
T14360 676-679 WRB denotes why
T14359 670-675 JJ denotes clear
T14358 666-669 RB denotes not
T14357 660-665 RB denotes still
T14356 657-659 VB denotes is
T14355 654-656 PRP denotes it
T14354 650-653 CC denotes and
T14353 646-649 NN denotes A20
T14352 643-645 IN denotes by
T14351 634-642 VB denotes targeted
T14350 629-633 RB denotes also
T14349 625-628 VB denotes are
T14348 619-624 DT denotes these
T14347 616-618 IN denotes of
T14346 611-615 JJ denotes Many
T14345 605-609 NN denotes TAK1
T14344 601-604 CC denotes and
T14343 596-600 NN denotes RIP1
T14342 594-595 -COMMA- denotes ,
T14341 589-594 NN denotes TRAF7
T14340 587-588 -COMMA- denotes ,
T14339 582-587 NN denotes TRAF6
T14338 580-581 -COMMA- denotes ,
T14337 575-580 NN denotes TRAF2
T14336 573-574 -COMMA- denotes ,
T14335 569-573 NN denotes NEMO
T14334 559-568 VB denotes including
T14333 550-558 NN denotes proteins
T14332 539-549 NN denotes signalling
T14331 533-538 NN denotes NF-κB
T14330 525-532 JJ denotes several
T14329 507-524 JJ denotes deubiquitina-ting
T14328 504-506 IN denotes by
T14327 502-503 -COMMA- denotes ,
T14326 501-502 -RRB- denotes )
T14325 500-501 CD denotes 1
T14324 493-499 NN denotes Figure
T14323 492-493 -LRB- denotes (
T14322 490-491 -RRB- denotes )
T14321 489-490 -RRB- denotes ]
T14320 487-489 CD denotes 64
T14319 486-487 -LRB- denotes [
T14318 483-485 IN denotes in
T14317 474-482 VB denotes reviewed
T14316 473-474 -LRB- denotes (
T14315 461-472 NN denotes stimulation
T14314 452-460 NN denotes receptor
T14313 445-451 NN denotes T-cell
T14312 441-444 CC denotes and
T14311 436-440 NN denotes RANK
T14310 434-435 -COMMA- denotes ,
T14309 430-434 NN denotes TNFR
T14308 427-429 IN denotes by
T14307 417-426 VB denotes initiated
T14306 406-416 NN denotes signalling
T14305 400-405 NN denotes NF-κB
T14304 390-399 VB denotes regulates
T14303 379-389 RB denotes negatively
T14302 374-378 WDT denotes that
T14301 367-373 NN denotes enzyme
T14300 350-366 VB denotes deubiquitinating
T14299 348-349 DT denotes a
T14298 345-347 VB denotes is
T14297 340-344 NN denotes CYLD
T14296 337-338 -RRB- denotes )
T14295 336-337 -RRB- denotes ]
T14294 334-336 CD denotes 64
T14293 333-334 -LRB- denotes [
T14292 330-332 IN denotes in
T14291 321-329 VB denotes reviewed
T14290 320-321 -LRB- denotes (
T14289 301-319 NN denotes osteoclastogenesis
T14288 297-300 CC denotes and
T14287 295-296 -COMMA- denotes ,
T14286 280-295 NN denotes spermatogenesis
T14285 278-279 -COMMA- denotes ,
T14284 267-278 NN denotes progression
T14283 261-266 NN denotes cycle
T14282 256-260 NN denotes cell
T14281 253-255 TO denotes to
T14280 240-252 NN denotes inflammation
T14279 236-239 CC denotes and
T14278 227-235 NN denotes immunity
T14277 222-226 IN denotes from
T14276 214-221 VB denotes ranging
T14275 204-213 NN denotes processes
T14274 190-203 JJ denotes physiological
T14273 182-189 JJ denotes diverse
T14272 179-181 IN denotes in
T14271 177-178 -COMMA- denotes ,
T14270 170-177 RB denotes however
T14269 168-169 -COMMA- denotes ,
T14268 160-168 VB denotes involved
T14267 155-159 RB denotes also
T14266 152-154 VB denotes is
R9626 T14515 T14516 arg1Of it,is
R9627 T14515 T14517 arg1Of it,worth
R9628 T14516 T14511 arg1Of is,In
R9347 T14245 T14244 arg1Of protein,Cylindromatosis
R9348 T14246 T14247 arg1Of Cylindromatosis,(
R9349 T14248 T14247 arg2Of CYLD,(
R9350 T14249 T14247 arg3Of ),(
R9351 T14250 T14246 arg1Of protein,Cylindromatosis
R9352 T14250 T14251 arg1Of protein,was
R9353 T14250 T14253 arg2Of protein,identified
R9354 T14253 T14251 arg2Of identified,was
R9355 T14253 T14252 arg1Of identified,originally
R9356 T14253 T14254 arg1Of identified,as
R9357 T14257 T14254 arg2Of suppressor,as
R9358 T14257 T14255 arg1Of suppressor,a
R9359 T14257 T14256 arg1Of suppressor,tumour
R9360 T14257 T14258 arg2Of suppressor,involved
R9361 T14258 T14259 arg1Of involved,in
R9362 T14261 T14259 arg2Of cylindromatosis,in
R9363 T14261 T14260 arg1Of cylindromatosis,familial
R9364 T14261 T14262 arg1Of cylindromatosis,[
R9365 T14263 T14262 arg2Of 63,[
R9366 T14264 T14262 arg3Of ],[
R9367 T14265 T14266 arg1Of CYLD,is
R9368 T14265 T14268 arg2Of CYLD,involved
R9369 T14268 T14266 arg2Of involved,is
R9370 T14268 T14267 arg1Of involved,also
R9371 T14268 T14269 arg1Of involved,","
R9372 T14268 T14270 arg1Of involved,however
R9373 T14268 T14271 arg1Of involved,","
R9374 T14268 T14272 arg1Of involved,in
R9375 T14275 T14272 arg2Of processes,in
R9376 T14275 T14273 arg1Of processes,diverse
R9377 T14275 T14274 arg1Of processes,physiological
R9378 T14275 T14276 arg1Of processes,ranging
R9379 T14276 T14277 arg1Of ranging,from
R9380 T14276 T14281 arg1Of ranging,to
R9381 T14278 T14279 arg1Of immunity,and
R9382 T14279 T14277 arg2Of and,from
R9383 T14280 T14279 arg2Of inflammation,and
R9384 T14284 T14282 arg1Of progression,cell
R9385 T14284 T14283 arg1Of progression,cycle
R9386 T14284 T14285 arg1Of progression,","
R9387 T14285 T14288 arg1Of ",",and
R9388 T14286 T14285 arg2Of spermatogenesis,","
R9389 T14288 T14281 arg2Of and,to
R9390 T14288 T14287 arg1Of and,","
R9391 T14289 T14288 arg2Of osteoclastogenesis,and
R9392 T14289 T14290 arg1Of osteoclastogenesis,(
R9393 T14291 T14290 arg2Of reviewed,(
R9394 T14291 T14292 arg1Of reviewed,in
R9395 T14291 T14293 arg1Of reviewed,[
R9396 T14294 T14293 arg2Of 64,[
R9397 T14295 T14293 arg3Of ],[
R9398 T14296 T14290 arg3Of ),(
R9399 T14297 T14298 arg1Of CYLD,is
R9400 T14298 T14327 arg1Of is,","
R9401 T14298 T14328 arg1Of is,by
R9402 T14301 T14298 arg2Of enzyme,is
R9403 T14301 T14299 arg1Of enzyme,a
R9404 T14301 T14300 arg1Of enzyme,deubiquitinating
R9405 T14301 T14302 arg1Of enzyme,that
R9406 T14301 T14304 arg1Of enzyme,regulates
R9407 T14304 T14303 arg1Of regulates,negatively
R9408 T14306 T14304 arg2Of signalling,regulates
R9409 T14306 T14305 arg1Of signalling,NF-κB
R9410 T14306 T14307 arg2Of signalling,initiated
R9411 T14306 T14316 arg1Of signalling,(
R9412 T14306 T14323 arg1Of signalling,(
R9413 T14309 T14310 arg1Of TNFR,","
R9414 T14310 T14312 arg1Of ",",and
R9415 T14311 T14310 arg2Of RANK,","
R9416 T14312 T14307 arg1Of and,initiated
R9417 T14312 T14308 arg2Of and,by
R9418 T14315 T14312 arg2Of stimulation,and
R9419 T14315 T14313 arg1Of stimulation,T-cell
R9420 T14315 T14314 arg1Of stimulation,receptor
R9421 T14317 T14316 arg2Of reviewed,(
R9422 T14317 T14318 arg1Of reviewed,in
R9423 T14317 T14319 arg1Of reviewed,[
R9424 T14320 T14319 arg2Of 64,[
R9425 T14321 T14319 arg3Of ],[
R9426 T14322 T14316 arg3Of ),(
R9427 T14324 T14323 arg2Of Figure,(
R9428 T14324 T14325 arg1Of Figure,1
R9429 T14326 T14323 arg3Of ),(
R9430 T14333 T14328 arg2Of proteins,by
R9431 T14333 T14329 arg1Of proteins,deubiquitina-ting
R9432 T14333 T14330 arg1Of proteins,several
R9433 T14333 T14331 arg1Of proteins,NF-κB
R9434 T14333 T14332 arg1Of proteins,signalling
R9435 T14333 T14334 arg1Of proteins,including
R9436 T14335 T14336 arg1Of NEMO,","
R9437 T14336 T14338 arg1Of ",",","
R9438 T14337 T14336 arg2Of TRAF2,","
R9439 T14338 T14340 arg1Of ",",","
R9440 T14339 T14338 arg2Of TRAF6,","
R9441 T14340 T14342 arg1Of ",",","
R9442 T14341 T14340 arg2Of TRAF7,","
R9443 T14342 T14344 arg1Of ",",and
R9444 T14343 T14342 arg2Of RIP1,","
R9445 T14344 T14334 arg2Of and,including
R9446 T14345 T14344 arg2Of TAK1,and
R9447 T14346 T14347 arg1Of Many,of
R9448 T14346 T14349 arg1Of Many,are
R9449 T14346 T14351 arg2Of Many,targeted
R9450 T14348 T14347 arg2Of these,of
R9451 T14351 T14349 arg2Of targeted,are
R9452 T14351 T14350 arg1Of targeted,also
R9453 T14351 T14354 arg1Of targeted,and
R9454 T14353 T14351 arg1Of A20,targeted
R9455 T14353 T14352 arg2Of A20,by
R9456 T14356 T14354 arg2Of is,and
R9457 T14356 T14357 arg1Of is,still
R9458 T14356 T14358 arg1Of is,not
R9459 T14359 T14356 arg2Of clear,is
R9460 T14360 T14355 arg1Of why,it
R9461 T14360 T14356 arg1Of why,is
R9462 T14360 T14359 arg1Of why,clear
R9463 T14362 T14361 arg1Of cell,the
R9464 T14362 T14363 arg1Of cell,needs
R9465 T14363 T14360 arg1Of needs,why
R9466 T14363 T14369 modOf needs,to
R9467 T14364 T14367 arg1Of A20,as
R9468 T14367 T14363 arg2Of as,needs
R9469 T14367 T14365 arg1Of as,as
R9470 T14367 T14366 arg1Of as,well
R9471 T14368 T14367 arg2Of CYLD,as
R9472 T14370 T14369 arg1Of control,to
R9473 T14372 T14370 arg2Of activation,control
R9474 T14372 T14371 arg1Of activation,NF-κB
R9475 T14374 T14375 arg1Of A20,is
R9476 T14374 T14377 arg2Of A20,expressed
R9477 T14377 T14373 arg2Of expressed,As
R9478 T14377 T14375 arg2Of expressed,is
R9479 T14377 T14376 arg1Of expressed,only
R9480 T14377 T14378 arg1Of expressed,in
R9481 T14377 T14382 arg1Of expressed,upon
R9482 T14381 T14378 arg2Of types,in
R9483 T14381 T14379 arg1Of types,many
R9484 T14381 T14380 arg1Of types,cell
R9485 T14383 T14382 arg2Of stimulation,upon
R9486 T14385 T14386 arg1Of it,has
R9487 T14385 T14387 arg1Of it,been
R9488 T14385 T14388 arg2Of it,suggested
R9489 T14388 T14373 arg1Of suggested,As
R9490 T14388 T14384 arg1Of suggested,","
R9491 T14388 T14386 arg2Of suggested,has
R9492 T14388 T14387 arg2Of suggested,been
R9493 T14391 T14390 arg1Of protein,this
R9494 T14391 T14393 arg1Of protein,regulates
R9495 T14393 T14392 arg1Of regulates,mainly
R9496 T14393 T14400 arg1Of regulates,whereas
R9497 T14395 T14393 arg2Of phases,regulates
R9498 T14395 T14394 arg1Of phases,later
R9499 T14395 T14396 arg1Of phases,of
R9500 T14398 T14396 arg2Of signalling,of
R9501 T14398 T14397 arg1Of signalling,NF-κB
R9502 T14400 T14388 arg3Of whereas,suggested
R9503 T14400 T14389 arg1Of whereas,that
R9504 T14400 T14399 arg1Of whereas,","
R9505 T14401 T14402 arg1Of CYLD,would
R9506 T14401 T14403 arg1Of CYLD,regulate
R9507 T14403 T14400 arg2Of regulate,whereas
R9508 T14403 T14402 arg2Of regulate,would
R9509 T14404 T14405 arg1Of constitutive,and
R9510 T14406 T14405 arg2Of early,and
R9511 T14407 T14403 arg2Of signalling,regulate
R9512 T14407 T14404 arg1Of signalling,constitutive
R9513 T14407 T14406 arg1Of signalling,early
R9514 T14409 T14408 arg2Of addition,In
R9515 T14413 T14411 arg1Of activity,their
R9516 T14413 T14412 arg1Of activity,relative
R9517 T14413 T14414 arg1Of activity,might
R9518 T14413 T14416 arg1Of activity,be
R9519 T14413 T14418 arg1Of activity,dependent
R9520 T14416 T14408 arg1Of be,In
R9521 T14416 T14410 arg1Of be,","
R9522 T14416 T14414 arg2Of be,might
R9523 T14416 T14415 arg1Of be,also
R9524 T14416 T14419 arg1Of be,[
R9525 T14418 T14416 arg2Of dependent,be
R9526 T14418 T14417 arg1Of dependent,cell-type
R9527 T14420 T14419 arg2Of 64,[
R9528 T14421 T14419 arg3Of ],[
R9529 T14424 T14425 arg1Of CYLD,has
R9530 T14424 T14426 arg1Of CYLD,been
R9531 T14424 T14427 arg2Of CYLD,shown
R9532 T14424 T14430 arg1Of CYLD,regulate
R9533 T14427 T14422 arg1Of shown,Interestingly
R9534 T14427 T14423 arg1Of shown,","
R9535 T14427 T14425 arg2Of shown,has
R9536 T14427 T14426 arg2Of shown,been
R9537 T14430 T14427 arg3Of regulate,shown
R9538 T14430 T14428 arg1Of regulate,to
R9539 T14430 T14429 arg1Of regulate,negatively
R9540 T14432 T14431 arg1Of signalling,RANK
R9541 T14432 T14433 arg1Of signalling,and
R9542 T14433 T14430 arg2Of and,regulate
R9543 T14433 T14435 arg1Of and,in
R9544 T14434 T14433 arg2Of osteoclastogenesis,and
R9545 T14436 T14435 arg2Of mice,in
R9546 T14436 T14437 arg1Of mice,[
R9547 T14438 T14437 arg2Of 65,[
R9548 T14439 T14437 arg3Of ],[
R9549 T14440 T14441 arg1Of Mice,with
R9550 T14440 T14447 arg1Of Mice,have
R9551 T14440 T14452 arg1Of Mice,develop
R9552 T14444 T14441 arg2Of deficiency,with
R9553 T14444 T14442 arg1Of deficiency,a
R9554 T14444 T14443 arg1Of deficiency,genetic
R9555 T14444 T14445 arg1Of deficiency,of
R9556 T14446 T14445 arg2Of CYLD,of
R9557 T14447 T14451 arg1Of have,and
R9558 T14450 T14447 arg2Of differentiation,have
R9559 T14450 T14448 arg1Of differentiation,aberrant
R9560 T14450 T14449 arg1Of differentiation,osteoclast
R9561 T14452 T14451 arg2Of develop,and
R9562 T14454 T14452 arg2Of osteoporosis,develop
R9563 T14454 T14453 arg1Of osteoporosis,severe
R9564 T14456 T14455 arg1Of precursors,Osteoclast
R9565 T14456 T14457 arg1Of precursors,of
R9566 T14456 T14460 arg1Of precursors,are
R9567 T14456 T14461 arg1Of precursors,hyper-responsive
R9568 T14456 T14466 arg1Of precursors,produce
R9569 T14459 T14457 arg2Of mice,of
R9570 T14459 T14458 arg1Of mice,these
R9571 T14460 T14465 arg1Of are,and
R9572 T14461 T14460 arg2Of hyper-responsive,are
R9573 T14461 T14462 arg1Of hyper-responsive,to
R9574 T14464 T14462 arg2Of differentiation,to
R9575 T14464 T14463 arg1Of differentiation,RANKL-induced
R9576 T14466 T14465 arg2Of produce,and
R9577 T14467 T14468 arg1Of more,and
R9578 T14469 T14468 arg2Of larger,and
R9579 T14470 T14466 arg2Of osteoclasts,produce
R9580 T14470 T14467 arg1Of osteoclasts,more
R9581 T14470 T14469 arg1Of osteoclasts,larger
R9582 T14472 T14471 arg1Of expression,CYLD
R9583 T14472 T14473 arg1Of expression,is
R9584 T14472 T14475 arg2Of expression,upregulated
R9585 T14472 T14482 arg1Of expression,is
R9586 T14472 T14483 arg2Of expression,recruited
R9587 T14475 T14473 arg2Of upregulated,is
R9588 T14475 T14474 arg1Of upregulated,markedly
R9589 T14475 T14476 arg1Of upregulated,under
R9590 T14475 T14481 arg1Of upregulated,and
R9591 T14477 T14476 arg2Of conditions,under
R9592 T14477 T14478 arg1Of conditions,of
R9593 T14480 T14478 arg2Of osteoclastogenesis,of
R9594 T14480 T14479 arg1Of osteoclastogenesis,RANKL-induced
R9595 T14481 T14503 arg1Of and,","
R9596 T14481 T14504 modOf and,followed
R9597 T14483 T14481 arg2Of recruited,and
R9598 T14483 T14482 arg2Of recruited,is
R9599 T14483 T14484 arg1Of recruited,to
R9600 T14483 T14487 arg1Of recruited,via
R9601 T14483 T14500 arg1Of recruited,[
R9602 T14486 T14484 arg2Of TRAF6,to
R9603 T14486 T14485 arg2Of TRAF6,ubiquitinated
R9604 T14492 T14487 arg2Of p62,via
R9605 T14492 T14488 arg1Of p62,the
R9606 T14492 T14489 arg1Of p62,ubiquitin-binding
R9607 T14492 T14490 arg1Of p62,adaptor
R9608 T14492 T14491 arg1Of p62,protein
R9609 T14492 T14493 arg1Of p62,(
R9610 T14495 T14493 arg2Of known,(
R9611 T14495 T14494 arg1Of known,also
R9612 T14495 T14496 arg1Of known,as
R9613 T14497 T14496 arg2Of sequestosome,as
R9614 T14497 T14498 arg1Of sequestosome,1
R9615 T14499 T14493 arg3Of ),(
R9616 T14501 T14500 arg2Of 65,[
R9617 T14502 T14500 arg3Of ],[
R9618 T14508 T14504 arg1Of deubiquitination,followed
R9619 T14508 T14505 arg2Of deubiquitination,by
R9620 T14508 T14506 arg1Of deubiquitination,the
R9621 T14508 T14507 arg1Of deubiquitination,CYLD-mediated
R9622 T14508 T14509 arg1Of deubiquitination,of
R9623 T14510 T14509 arg2Of TRAF6,of
R9624 T14513 T14511 arg2Of context,In
R9625 T14513 T14512 arg1Of context,this
R9629 T14516 T14514 arg1Of is,","
R9630 T14517 T14516 arg2Of worth,is
R9631 T14518 T14517 arg2Of mentioning,worth
R9632 T14521 T14520 arg1Of mice,transgenic
R9633 T14521 T14522 arg1Of mice,expressing
R9634 T14521 T14529 arg1Of mice,display
R9635 T14521 T14533 arg1Of mice,develop
R9636 T14525 T14522 arg2Of form,expressing
R9637 T14525 T14523 arg1Of form,a
R9638 T14525 T14524 arg2Of form,mutated
R9639 T14525 T14526 arg1Of form,of
R9640 T14527 T14526 arg2Of p62,of
R9641 T14529 T14532 arg1Of display,and
R9642 T14531 T14529 arg2Of osteoclastogenesis,display
R9643 T14531 T14530 arg1Of osteoclastogenesis,abnormal
R9644 T14532 T14518 arg2Of and,mentioning
R9645 T14532 T14519 arg1Of and,that
R9646 T14532 T14528 arg1Of and,also
R9647 T14533 T14532 arg2Of develop,and
R9648 T14533 T14537 arg1Of develop,[
R9649 T14536 T14533 arg2Of loss,develop
R9650 T14536 T14534 arg1Of loss,progressive
R9651 T14536 T14535 arg1Of loss,bone
R9652 T14538 T14537 arg2Of 66,[
R9653 T14539 T14537 arg3Of ],[
R9654 T14541 T14540 arg1Of findings,These
R9655 T14541 T14542 arg1Of findings,suggest
R9656 T14545 T14544 arg1Of inhibi-tion,CYLD-mediated
R9657 T14545 T14546 arg1Of inhibi-tion,of
R9658 T14545 T14550 arg1Of inhibi-tion,plays
R9659 T14545 T14561 arg1Of inhibi-tion,indicate
R9660 T14549 T14546 arg2Of signalling,of
R9661 T14549 T14547 arg1Of signalling,RANK-induced
R9662 T14549 T14548 arg1Of signalling,NF-κB
R9663 T14550 T14554 arg1Of plays,in
R9664 T14550 T14560 arg1Of plays,and
R9665 T14553 T14550 arg2Of role,plays
R9666 T14553 T14551 arg1Of role,a
R9667 T14553 T14552 arg1Of role,key
R9668 T14557 T14554 arg2Of regulation,in
R9669 T14557 T14555 arg1Of regulation,the
R9670 T14557 T14556 arg1Of regulation,negative
R9671 T14557 T14558 arg1Of regulation,of
R9672 T14559 T14558 arg2Of osteoclastogenesis,of
R9673 T14560 T14542 arg2Of and,suggest
R9674 T14560 T14543 arg1Of and,that
R9675 T14561 T14560 arg2Of indicate,and
R9676 T14561 T14563 arg1Of indicate,as
R9677 T14562 T14561 arg2Of CYLD,indicate
R9678 T14567 T14563 arg2Of factor,as
R9679 T14567 T14564 arg1Of factor,a
R9680 T14567 T14565 arg1Of factor,potential
R9681 T14567 T14566 arg1Of factor,genetic
R9682 T14567 T14568 arg2Of factor,involved
R9683 T14568 T14569 arg1Of involved,in
R9684 T14571 T14569 arg2Of pathology,in
R9685 T14571 T14570 arg1Of pathology,the
R9686 T14571 T14572 arg1Of pathology,of
R9687 T14574 T14572 arg2Of disorders,of
R9688 T14574 T14573 arg1Of disorders,bone
R9689 T14574 T14576 arg1Of disorders,as
R9690 T14576 T14575 arg1Of as,such
R9691 T14577 T14576 arg2Of RA,as

GO-BP

Id Subject Object Predicate Lexical cue
T14593 1960-1970 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T14592 1638-1654 http://purl.obolibrary.org/obo/GO_0016579 denotes deubiquitination
T14591 1201-1227 http://purl.obolibrary.org/obo/GO_0030316 denotes osteoclast differentiation
T14590 726-742 http://purl.obolibrary.org/obo/GO_0051092 denotes NF-κB activation
T14589 1916-1926 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T14588 1100-1110 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T14587 948-958 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T14586 885-895 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T14585 539-549 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T14584 406-416 http://purl.obolibrary.org/obo/GO_0023052 denotes signalling
T14583 350-373 http://purl.obolibrary.org/obo/GO_0004843 denotes deubiquitinating enzyme
T14582 280-295 http://purl.obolibrary.org/obo/GO_0007283 denotes spermatogenesis
T14581 256-278 http://purl.obolibrary.org/obo/GO_0051726 denotes cell cycle progression
T14580 256-278 http://purl.obolibrary.org/obo/GO_0007050 denotes cell cycle progression
T14579 256-266 http://purl.obolibrary.org/obo/GO_0007049 denotes cell cycle
T14578 240-252 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

GO-MF

Id Subject Object Predicate Lexical cue
T14599 1543-1550 http://purl.obolibrary.org/obo/GO_0005488 denotes binding
T14598 1533-1550 http://purl.obolibrary.org/obo/GO_0043130 denotes ubiquitin-binding
T14597 1533-1542 http://purl.obolibrary.org/obo/GO_0031386 denotes ubiquitin
T14596 350-373 http://purl.obolibrary.org/obo/GO_0004843 denotes deubiquitinating enzyme

GO-CC

Id Subject Object Predicate Lexical cue
T14604 1011-1015 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T14603 777-781 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T14602 684-688 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T14601 447-451 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T14600 256-260 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

sentences

Id Subject Object Predicate Lexical cue
T14151 1840-2096 Sentence denotes These findings suggest that CYLD-mediated inhibi-tion of RANK-induced NF-κB signalling plays a key role in the negative regulation of osteoclastogenesis and indicate CYLD as a potential genetic factor involved in the pathology of bone disorders such as RA.
T14150 1665-1839 Sentence denotes In this context, it is worth mentioning that transgenic mice expressing a mutated form of p62 also display abnormal osteoclastogenesis and develop progressive bone loss [66].
T14149 1392-1664 Sentence denotes CYLD expression is markedly upregulated under conditions of RANKL-induced osteoclastogenesis and is recruited to ubiquitinated TRAF6 via the ubiquitin-binding adaptor protein p62 (also known as sequestosome 1) [65], followed by the CYLD-mediated deubiquitination of TRAF6.
T14148 1261-1391 Sentence denotes Osteoclast precursors of these mice are hyper-responsive to RANKL-induced differentiation and produce more and larger osteoclasts.
T14147 1148-1260 Sentence denotes Mice with a genetic deficiency of CYLD have aberrant osteoclast differentiation and develop severe osteoporosis.
T14146 1037-1147 Sentence denotes Interestingly, CYLD has been shown to negatively regulate RANK signalling and osteoclastogenesis in mice [65].
T14145 960-1036 Sentence denotes In addition, their relative activity might also be cell-type dependent [64].
T14144 744-959 Sentence denotes As A20 is only expressed in many cell types upon stimulation, it has been suggested that this protein mainly regulates later phases of NF-κB signalling, whereas CYLD would regulate constitutive and early signalling.
T14143 611-743 Sentence denotes Many of these are also targeted by A20 and it is still not clear why the cell needs A20 as well as CYLD to control NF-κB activation.
T14142 340-610 Sentence denotes CYLD is a deubiquitinating enzyme that negatively regulates NF-κB signalling initiated by TNFR, RANK and T-cell receptor stimulation (reviewed in [64]) (Figure 1), by deubiquitina-ting several NF-κB signalling proteins including NEMO, TRAF2, TRAF6, TRAF7, RIP1 and TAK1.
T14141 147-339 Sentence denotes CYLD is also involved, however, in diverse physiological processes ranging from immunity and inflammation to cell cycle progression, spermatogenesis, and osteoclastogenesis (reviewed in [64]).
T14140 24-146 Sentence denotes Cylindromatosis (CYLD) protein was originally identified as a tumour suppressor involved in familial cylindromatosis [63].
T14139 0-23 Sentence denotes Cylindromatosis protein
T139 0-23 Sentence denotes Cylindromatosis protein
T140 24-146 Sentence denotes Cylindromatosis (CYLD) protein was originally identified as a tumour suppressor involved in familial cylindromatosis [63].
T141 147-339 Sentence denotes CYLD is also involved, however, in diverse physiological processes ranging from immunity and inflammation to cell cycle progression, spermatogenesis, and osteoclastogenesis (reviewed in [64]).
T142 340-610 Sentence denotes CYLD is a deubiquitinating enzyme that negatively regulates NF-κB signalling initiated by TNFR, RANK and T-cell receptor stimulation (reviewed in [64]) (Figure 1), by deubiquitina-ting several NF-κB signalling proteins including NEMO, TRAF2, TRAF6, TRAF7, RIP1 and TAK1.
T143 611-743 Sentence denotes Many of these are also targeted by A20 and it is still not clear why the cell needs A20 as well as CYLD to control NF-κB activation.
T144 744-959 Sentence denotes As A20 is only expressed in many cell types upon stimulation, it has been suggested that this protein mainly regulates later phases of NF-κB signalling, whereas CYLD would regulate constitutive and early signalling.
T145 960-1036 Sentence denotes In addition, their relative activity might also be cell-type dependent [64].
T146 1037-1147 Sentence denotes Interestingly, CYLD has been shown to negatively regulate RANK signalling and osteoclastogenesis in mice [65].
T147 1148-1260 Sentence denotes Mice with a genetic deficiency of CYLD have aberrant osteoclast differentiation and develop severe osteoporosis.
T148 1261-1391 Sentence denotes Osteoclast precursors of these mice are hyper-responsive to RANKL-induced differentiation and produce more and larger osteoclasts.
T149 1392-1664 Sentence denotes CYLD expression is markedly upregulated under conditions of RANKL-induced osteoclastogenesis and is recruited to ubiquitinated TRAF6 via the ubiquitin-binding adaptor protein p62 (also known as sequestosome 1) [65], followed by the CYLD-mediated deubiquitination of TRAF6.
T150 1665-1839 Sentence denotes In this context, it is worth mentioning that transgenic mice expressing a mutated form of p62 also display abnormal osteoclastogenesis and develop progressive bone loss [66].
T151 1840-2096 Sentence denotes These findings suggest that CYLD-mediated inhibi-tion of RANK-induced NF-κB signalling plays a key role in the negative regulation of osteoclastogenesis and indicate CYLD as a potential genetic factor involved in the pathology of bone disorders such as RA.

ICD10

Id Subject Object Predicate Lexical cue
T14595 2070-2084 http://purl.bioontology.org/ontology/ICD10/M89.9 denotes bone disorders
T14594 1247-1259 http://purl.bioontology.org/ontology/ICD10/M81.9 denotes osteoporosis

simple1

Id Subject Object Predicate Lexical cue
T14638 2006-2010 Protein denotes CYLD
T14637 1897-1901 Protein denotes RANK
T14636 1868-1872 Protein denotes CYLD
T14635 1755-1758 Protein denotes p62
T14634 1658-1663 Protein denotes TRAF6
T14633 1624-1628 Protein denotes CYLD
T14632 1586-1600 Protein denotes sequestosome 1
T14631 1567-1570 Protein denotes p62
T14630 1533-1542 Protein denotes ubiquitin
T14629 1519-1524 Protein denotes TRAF6
T14628 1452-1457 Protein denotes RANKL
T14627 1392-1396 Protein denotes CYLD
T14626 1321-1326 Protein denotes RANKL
T14625 1182-1186 Protein denotes CYLD
T14624 1095-1099 Protein denotes RANK
T14623 1052-1056 Protein denotes CYLD
T14622 905-909 Protein denotes CYLD
T14621 747-750 Protein denotes A20
T14620 710-714 Protein denotes CYLD
T14619 695-698 Protein denotes A20
T14618 646-649 Protein denotes A20
T14617 605-609 Protein denotes TAK1
T14616 596-600 Protein denotes RIP1
T14615 589-594 Protein denotes TRAF7
T14614 582-587 Protein denotes TRAF6
T14613 575-580 Protein denotes TRAF2
T14612 569-573 Protein denotes NEMO
T14611 436-440 Protein denotes RANK
T14610 350-373 Protein denotes deubiquitinating enzyme
T14609 340-344 Protein denotes CYLD
T14608 147-151 Protein denotes CYLD
T14607 41-45 Protein denotes CYLD
T14606 24-39 Protein denotes Cylindromatosis
T14605 0-15 Protein denotes Cylindromatosis

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T15301 1726-1736 Gene_expression denotes expressing
T15300 1397-1407 Gene_expression denotes expression
T15299 1543-1550 Binding denotes binding
T15298 1638-1654 Negative_regulation denotes deubiquitination
T15297 1420-1431 Positive_regulation denotes upregulated
T15296 1168-1178 Negative_regulation denotes deficiency
T15295 759-768 Gene_expression denotes expressed
T15294 634-642 Binding denotes targeted
T15293 2006-2010 Protein denotes CYLD
T15292 1897-1901 Protein denotes RANK
T15291 1868-1872 Protein denotes CYLD
T15290 1755-1758 Protein denotes p62
T15289 1658-1663 Protein denotes TRAF6
T15288 1624-1628 Protein denotes CYLD
T15287 1586-1600 Protein denotes sequestosome 1
T15286 1567-1570 Protein denotes p62
T15285 1533-1542 Protein denotes ubiquitin
T15284 1519-1524 Protein denotes TRAF6
T15283 1452-1457 Protein denotes RANKL
T15282 1392-1396 Protein denotes CYLD
T15281 1321-1326 Protein denotes RANKL
T15280 1182-1186 Protein denotes CYLD
T15279 1095-1099 Protein denotes RANK
T15278 1052-1056 Protein denotes CYLD
T15277 905-909 Protein denotes CYLD
T15276 747-750 Protein denotes A20
T15275 710-714 Protein denotes CYLD
T15274 695-698 Protein denotes A20
T15273 646-649 Protein denotes A20
T15272 575-580 Protein denotes TRAF2
T15271 569-573 Protein denotes NEMO
T15270 436-440 Protein denotes RANK
T15269 350-373 Protein denotes deubiquitinating enzyme
T15268 340-344 Protein denotes CYLD
T15267 605-609 Protein denotes TAK1
T15266 596-600 Protein denotes RIP1
T15265 589-594 Protein denotes TRAF7
T15264 582-587 Protein denotes TRAF6
T15263 147-151 Protein denotes CYLD
T15262 41-45 Protein denotes CYLD
T15261 24-39 Protein denotes Cylindromatosis
T15260 0-15 Protein denotes Cylindromatosis
R10133 T15273 T15294 themeOf A20,targeted
R10134 T15276 T15295 themeOf A20,expressed
R10135 T15280 T15296 themeOf CYLD,deficiency
R10136 T15282 T15300 themeOf CYLD,expression
R10137 T15285 T15299 themeOf ubiquitin,binding
R10138 T15286 T15299 themeOf p62,binding
R10139 T15286 T15300 themeOf p62,expression
R10140 T15289 T15298 themeOf TRAF6,deubiquitination
R10141 T15290 T15301 themeOf p62,expressing
R10142 T15300 T15297 themeOf expression,upregulated
R10143 T15300 T15297 themeOf expression,upregulated

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T15071 1726-1736 Gene_expression denotes expressing
T15069 1420-1431 Positive_regulation denotes upregulated
T15068 1492-1501 Binding denotes recruited
T15067 1638-1654 Negative_regulation denotes deubiquitination
T15066 1397-1407 Gene_expression denotes expression
T15065 1327-1334 Positive_regulation denotes induced
T15064 1168-1178 Negative_regulation denotes deficiency
T15063 759-768 Gene_expression denotes expressed
T15062 2006-2010 Protein denotes CYLD
T15061 1897-1901 Protein denotes RANK
T15060 1868-1872 Protein denotes CYLD
T15059 1755-1758 Protein denotes p62
T15058 1658-1663 Protein denotes TRAF6
T15057 1624-1628 Protein denotes CYLD
T15056 1586-1600 Protein denotes sequestosome 1
T15055 1567-1570 Protein denotes p62
T15054 1533-1542 Protein denotes ubiquitin
T15053 1519-1524 Protein denotes TRAF6
T15052 1452-1457 Protein denotes RANKL
T15051 1392-1396 Protein denotes CYLD
T15050 1321-1326 Protein denotes RANKL
T15049 1182-1186 Protein denotes CYLD
T15048 1095-1099 Protein denotes RANK
T15047 1052-1056 Protein denotes CYLD
T15046 905-909 Protein denotes CYLD
T15045 747-750 Protein denotes A20
T15044 710-714 Protein denotes CYLD
T15043 695-698 Protein denotes A20
T15042 646-649 Protein denotes A20
T15041 575-580 Protein denotes TRAF2
T15040 569-573 Protein denotes NEMO
T15039 436-440 Protein denotes RANK
T15038 350-373 Protein denotes deubiquitinating enzyme
T15037 340-344 Protein denotes CYLD
T15036 605-609 Protein denotes TAK1
T15035 596-600 Protein denotes RIP1
T15034 589-594 Protein denotes TRAF7
T15033 582-587 Protein denotes TRAF6
T15032 147-151 Protein denotes CYLD
T15031 41-45 Protein denotes CYLD
T15030 24-39 Protein denotes Cylindromatosis
T15029 0-15 Protein denotes Cylindromatosis
T15070 1543-1550 Binding denotes binding
R10041 T15045 T15063 themeOf A20,expressed
R10042 T15049 T15064 themeOf CYLD,deficiency
R10043 T15050 T15065 themeOf RANKL,induced
R10044 T15051 T15066 themeOf CYLD,expression
R10045 T15054 T15070 themeOf ubiquitin,binding
R10046 T15055 T15068 themeOf p62,recruited
R10047 T15055 T15070 themeOf p62,binding
R10048 T15058 T15067 themeOf TRAF6,deubiquitination
R10049 T15059 T15071 themeOf p62,expressing
R10050 T15066 T15069 themeOf expression,upregulated

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T15367 1505-1524 Ubiquitination denotes ubiquitinated TRAF6
T15366 400-426 Positive_regulation denotes NF-κB signalling initiated
T15365 1037-1146 Regulation denotes Interestingly, CYLD has been shown to negatively regulate RANK signalling and osteoclastogenesis in mice [65]
T15364 445-461 Localization denotes T-cell receptor
T15363 445-472 Positive_regulation denotes T-cell receptor stimulation
T15362 1617-1663 Regulation denotes by the CYLD-mediated deubiquitination of TRAF6
T15361 1392-1407 Gene_expression denotes CYLD expression
T15360 695-742 Regulation denotes A20 as well as CYLD to control NF-κB activation
T15359 726-742 Positive_regulation denotes NF-κB activation
T15358 374-472 Regulation denotes that negatively regulates NF-κB signalling initiated by TNFR, RANK and T-cell receptor stimulation
T15357 1452-1465 Protein denotes RANKL-induced
T15356 1868-1881 Protein denotes CYLD-mediated
T15355 905-909 Protein denotes CYLD
T15354 367-472 Protein denotes enzyme that negatively regulates NF-κB signalling initiated by TNFR, RANK and T-cell receptor stimulation
T15353 1752-1758 Protein denotes of p62
T15352 1261-1296 Entity denotes Osteoclast precursors of these mice
T15351 2070-2095 Protein denotes bone disorders such as RA
T15350 147-151 Protein denotes CYLD
T15349 726-731 Protein denotes NF-κB
T15348 833-845 Protein denotes this protein
T15347 569-573 Protein denotes NEMO
T15346 2006-2010 Protein denotes CYLD
T15345 1095-1146 Protein denotes RANK signalling and osteoclastogenesis in mice [65]
T15344 643-649 Protein denotes by A20
T15343 1052-1056 Protein denotes CYLD
T15342 747-750 Protein denotes A20
T15341 1586-1600 Protein denotes sequestosome 1
T15340 430-434 Protein denotes TNFR
T15339 445-451 Entity denotes T-cell
T15338 605-609 Protein denotes TAK1
T15337 1179-1186 Protein denotes of CYLD
T15336 772-787 Entity denotes many cell types
T15335 0-23 Protein denotes Cylindromatosis protein
T15334 1655-1663 Protein denotes of TRAF6
T15333 24-46 Protein denotes Cylindromatosis (CYLD)
T15332 507-558 Protein denotes deubiquitina-ting several NF-κB signalling proteins
T15331 589-594 Protein denotes TRAF7
T15330 1505-1524 Protein denotes ubiquitinated TRAF6
T15329 695-714 Protein denotes A20 as well as CYLD
T15328 575-580 Protein denotes TRAF2
T15327 1897-1926 Protein denotes RANK-induced NF-κB signalling
T15326 1372-1390 Entity denotes larger osteoclasts
T15325 1551-1570 Protein denotes adaptor protein p62
T15324 41-45 Protein denotes CYLD
T15323 1148-1186 Protein denotes Mice with a genetic deficiency of CYLD
T15322 1897-1909 Protein denotes RANK-induced
T15321 0-15 Protein denotes Cylindromatosis
T15320 1551-1570 Protein denotes adaptor protein p62
T15319 1011-1030 Entity denotes cell-type dependent
T15318 1529-1550 Protein denotes the ubiquitin-binding
T15317 507-558 Protein denotes deubiquitina-ting several NF-κB signalling proteins
T15316 710-714 Protein denotes CYLD
T15315 436-440 Protein denotes RANK
T15314 1392-1396 Protein denotes CYLD
T15313 876-895 Protein denotes of NF-κB signalling
T15312 1624-1637 Protein denotes CYLD-mediated
T15311 1321-1326 Protein denotes RANKL
T15310 596-600 Protein denotes RIP1
T15309 582-587 Protein denotes TRAF6
T15308 24-54 Protein denotes Cylindromatosis (CYLD) protein
T15307 445-460 Protein denotes T-cell receptor
T15306 340-344 Protein denotes CYLD
T15305 680-688 Entity denotes the cell
T15304 400-405 Protein denotes NF-κB
T15303 1137-1146 Protein denotes mice [65]
T15302 113-145 Protein denotes in familial cylindromatosis [63]
R10144 T15304 T15358 themeOf NF-κB,"that negatively regulates NF-κB signalling initiated by TNFR, RANK and T-cell receptor stimulation"
R10145 T15304 T15366 themeOf NF-κB,NF-κB signalling initiated
R10146 T15307 T15363 themeOf T-cell receptor,T-cell receptor stimulation
R10147 T15307 T15364 themeOf T-cell receptor,T-cell receptor
R10148 T15312 T15362 causeOf CYLD-mediated,by the CYLD-mediated deubiquitination of TRAF6
R10149 T15314 T15361 themeOf CYLD,CYLD expression
R10150 T15329 T15360 causeOf A20 as well as CYLD,A20 as well as CYLD to control NF-κB activation
R10151 T15330 T15367 themeOf ubiquitinated TRAF6,ubiquitinated TRAF6
R10152 T15339 T15364 locationOf T-cell,T-cell receptor
R10153 T15343 T15365 causeOf CYLD,"Interestingly, CYLD has been shown to negatively regulate RANK signalling and osteoclastogenesis in mice [65]"
R10154 T15345 T15365 themeOf RANK signalling and osteoclastogenesis in mice [65],"Interestingly, CYLD has been shown to negatively regulate RANK signalling and osteoclastogenesis in mice [65]"
R10155 T15349 T15359 themeOf NF-κB,NF-κB activation
R10156 T15359 T15360 themeOf NF-κB activation,A20 as well as CYLD to control NF-κB activation

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T15167 2006-2010 Protein denotes CYLD
T15166 1910-1915 Protein denotes NF-κB
T15165 1897-1901 Protein denotes RANK
T15164 1726-1736 Gene_expression denotes expressing
T15163 1755-1758 Protein denotes p62
T15162 1492-1501 Negative_regulation denotes recruited
T15161 1420-1431 Positive_regulation denotes upregulated
T15160 1397-1407 Gene_expression denotes expression
T15159 1658-1663 Protein denotes TRAF6
T15158 1567-1570 Protein denotes p62
T15157 1533-1542 Protein denotes ubiquitin
T15156 1505-1524 Protein denotes ubiquitinated TRAF6
T15155 1452-1457 Protein denotes RANKL
T15154 1392-1396 Protein denotes CYLD
T15153 1321-1326 Protein denotes RANKL
T15152 1168-1178 Negative_regulation denotes deficiency
T15151 1182-1186 Protein denotes CYLD
T15150 1086-1094 Regulation denotes regulate
T15149 1095-1099 Protein denotes RANK
T15148 1052-1056 Protein denotes CYLD
T15147 853-862 Regulation denotes regulates
T15146 879-884 Protein denotes NF-κB
T15145 718-725 Regulation denotes control
T15144 732-742 Positive_regulation denotes activation
T15143 726-731 Protein denotes NF-κB
T15142 710-714 Protein denotes CYLD
T15141 390-399 Regulation denotes regulates
T15140 390-399 Regulation denotes regulates
T15139 390-399 Regulation denotes regulates
T15138 390-399 Regulation denotes regulates
T15137 390-399 Regulation denotes regulates
T15136 390-399 Regulation denotes regulates
T15135 390-399 Regulation denotes regulates
T15134 507-524 Gene_expression denotes deubiquitina-ting
T15133 507-524 Gene_expression denotes deubiquitina-ting
T15132 507-524 Gene_expression denotes deubiquitina-ting
T15131 507-524 Gene_expression denotes deubiquitina-ting
T15130 507-524 Gene_expression denotes deubiquitina-ting
T15129 507-524 Gene_expression denotes deubiquitina-ting
T15128 507-524 Gene_expression denotes deubiquitina-ting
T15127 605-609 Protein denotes TAK1
T15126 596-600 Protein denotes RIP1
T15125 589-594 Protein denotes TRAF7
T15124 582-587 Protein denotes TRAF6
T15123 575-580 Protein denotes TRAF2
T15122 569-573 Protein denotes NEMO
T15121 533-558 Protein denotes NF-κB signalling proteins
T15120 445-460 Protein denotes T-cell receptor
T15119 436-440 Protein denotes RANK
T15118 430-434 Protein denotes TNFR
T15117 400-405 Protein denotes NF-κB
T15116 340-344 Protein denotes CYLD
T15115 147-151 Protein denotes CYLD
R10062 T15117 T15135 themeOf NF-κB,regulates
R10063 T15117 T15136 themeOf NF-κB,regulates
R10064 T15117 T15137 themeOf NF-κB,regulates
R10065 T15117 T15138 themeOf NF-κB,regulates
R10066 T15117 T15139 themeOf NF-κB,regulates
R10067 T15117 T15140 themeOf NF-κB,regulates
R10068 T15117 T15141 themeOf NF-κB,regulates
R10069 T15121 T15128 themeOf NF-κB signalling proteins,deubiquitina-ting
R10070 T15122 T15129 themeOf NEMO,deubiquitina-ting
R10071 T15123 T15130 themeOf TRAF2,deubiquitina-ting
R10072 T15124 T15131 themeOf TRAF6,deubiquitina-ting
R10073 T15125 T15132 themeOf TRAF7,deubiquitina-ting
R10074 T15126 T15133 themeOf RIP1,deubiquitina-ting
R10075 T15127 T15134 themeOf TAK1,deubiquitina-ting
R10076 T15135 T15128 Cause regulates,deubiquitina-ting
R10077 T15136 T15129 Cause regulates,deubiquitina-ting
R10078 T15137 T15130 Cause regulates,deubiquitina-ting
R10079 T15138 T15131 Cause regulates,deubiquitina-ting
R10080 T15139 T15132 Cause regulates,deubiquitina-ting
R10081 T15140 T15133 Cause regulates,deubiquitina-ting
R10082 T15141 T15134 Cause regulates,deubiquitina-ting
R10083 T15143 T15144 themeOf NF-κB,activation
R10084 T15144 T15145 themeOf activation,control
R10085 T15145 T15142 Cause control,CYLD
R10086 T15146 T15147 themeOf NF-κB,regulates
R10087 T15149 T15150 themeOf RANK,regulate
R10088 T15150 T15148 Cause regulate,CYLD
R10089 T15151 T15152 themeOf CYLD,deficiency
R10090 T15154 T15160 themeOf CYLD,expression
R10091 T15160 T15161 themeOf expression,upregulated
R10092 T15160 T15162 themeOf expression,recruited
R10093 T15163 T15164 themeOf p62,expressing

test3

Id Subject Object Predicate Lexical cue
T14138 2006-2010 Protein denotes CYLD
T14137 1897-1901 Protein denotes RANK
T14136 1868-1872 Protein denotes CYLD
T14135 1755-1758 Protein denotes p62
T14134 1658-1663 Protein denotes TRAF6
T14133 1629-1637 Positive_regulation denotes mediated
T14132 1624-1628 Protein denotes CYLD
T14131 1586-1600 Protein denotes sequestosome 1
T14130 1567-1570 Protein denotes p62
T14129 1543-1550 Binding denotes binding
T14128 1533-1542 Protein denotes ubiquitin
T14127 1525-1528 Positive_regulation denotes via
T14126 1519-1524 Protein denotes TRAF6
T14125 1492-1501 Binding denotes recruited
T14124 1458-1465 Positive_regulation denotes induced
T14123 1452-1457 Protein denotes RANKL
T14122 1392-1396 Protein denotes CYLD
T14121 1321-1326 Protein denotes RANKL
T14120 1182-1186 Protein denotes CYLD
T14119 1095-1099 Protein denotes RANK
T14118 1052-1056 Protein denotes CYLD
T14117 905-909 Protein denotes CYLD
T14116 759-768 Gene_expression denotes expressed
T14115 747-750 Protein denotes A20
T14114 710-714 Protein denotes CYLD
T14113 695-698 Protein denotes A20
T14112 646-649 Protein denotes A20
T14111 605-609 Protein denotes TAK1
T14110 596-600 Protein denotes RIP1
T14109 589-594 Protein denotes TRAF7
T14108 582-587 Protein denotes TRAF6
T14107 575-580 Protein denotes TRAF2
T14106 569-573 Protein denotes NEMO
T14105 436-440 Protein denotes RANK
T14104 350-373 Protein denotes deubiquitinating enzyme
T14103 340-344 Protein denotes CYLD
T14102 147-151 Protein denotes CYLD
T14101 41-45 Protein denotes CYLD
T14100 24-39 Protein denotes Cylindromatosis
T14099 0-15 Protein denotes Cylindromatosis
T14098 2006-2010 Protein denotes CYLD
T14097 1897-1901 Protein denotes RANK
T14096 1868-1872 Protein denotes CYLD
T14095 1755-1758 Protein denotes p62
T14094 1658-1663 Protein denotes TRAF6
T14093 1624-1628 Protein denotes CYLD
T14092 1586-1600 Protein denotes sequestosome 1
T14091 1567-1570 Protein denotes p62
T14090 1533-1542 Protein denotes ubiquitin
T14089 1519-1524 Protein denotes TRAF6
T14088 1452-1457 Protein denotes RANKL
T14087 1392-1396 Protein denotes CYLD
T14086 1321-1326 Protein denotes RANKL
T14085 1182-1186 Protein denotes CYLD
T14084 1095-1099 Protein denotes RANK
T14083 1052-1056 Protein denotes CYLD
T14082 905-909 Protein denotes CYLD
T14081 747-750 Protein denotes A20
T14080 710-714 Protein denotes CYLD
T14079 695-698 Protein denotes A20
T14078 646-649 Protein denotes A20
T14077 605-609 Protein denotes TAK1
T14076 596-600 Protein denotes RIP1
T14075 589-594 Protein denotes TRAF7
T14074 582-587 Protein denotes TRAF6
T14073 575-580 Protein denotes TRAF2
T14072 569-573 Protein denotes NEMO
T14071 436-440 Protein denotes RANK
T14070 350-373 Protein denotes deubiquitinating enzyme
T14069 340-344 Protein denotes CYLD
T14068 147-151 Protein denotes CYLD
T14067 41-45 Protein denotes CYLD
T14066 24-39 Protein denotes Cylindromatosis
T14065 0-15 Protein denotes Cylindromatosis
R9301 T14101 T14100 equivalentTo CYLD,Cylindromatosis
R9302 T14103 T14105 themeOf CYLD,RANK
R9303 T14103 T14104 themeOf CYLD,deubiquitinating enzyme
R9304 T14104 T14105 themeOf deubiquitinating enzyme,RANK
R9305 T14115 T14116 themeOf A20,expressed
R9306 T14118 T14119 themeOf CYLD,RANK
R9307 T14123 T14124 causeOf RANKL,induced
R9308 T14126 T14125 themeOf TRAF6,recruited
R9309 T14130 T14129 themeOf p62,binding
R9310 T14131 T14127 causeOf sequestosome 1,via
R9311 T14132 T14133 causeOf CYLD,mediated